Page last updated: 2024-08-23

etoposide and procarbazine

etoposide has been researched along with procarbazine in 426 studies

Research

Studies (426)

TimeframeStudies, this research(%)All Research%
pre-199046 (10.80)18.7374
1990's107 (25.12)18.2507
2000's111 (26.06)29.6817
2010's143 (33.57)24.3611
2020's19 (4.46)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Amiel, JL; Hayat, M; Mathé, G; Pouillart, P; Schwarzenberg, L; Tubiana, M1
Bunn, PA; Chretien, PB; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston, AV; Kenady, DE; Lipson, SD; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE1
Bunn, PA; Cohen, MH; Fossieck, BE; Ihde, DC; Johnston-Early, A; Makuch, R; Matthews, MJ; Minna, JD; Shackney, SE1
Abeloff, MD; Ettinger, DS; Khouri, NF; Lenhard, RE1
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U2
Fuse, Y; Katayama, Y; Kitamura, H; Kugai, N; Matsuura, Y; Motoyoshi, K; Nagata, N; Ohkawa, H; Wada, S1
Li, LY1
Higuchi, S; Itoh, T; Kishibe, T; Sakata, Y; Seino, Y; Sohma, N; Sugimoto, N; Suzuki, H1
Arnott, S; D'Ardenne, J; Ganesan, TS; Lister, TA; Oza, A; Perry, N; Shand, WS; Stansfeld, AG; Wrigley, PF1
Agthe, A; Brittinger, G; Engelhard, M; Griesser, H; Huhn, D; Kuse, R; Lennert, K; Schwerdtfeger, R; Siegert, W; Tiemann, M1
Alberto, P; Mermillod, B; Zulian, GB1
Weiss, RB1
Bosly, A; Doyen, C; Ferrant, A; Machiels, JP; Martiat, P; Michaux, JL1
Brämswig, JH; Hörnig-Franz, I; Schellong, G1
Solal-Céligny, P1
Anderson, L; Bennett, MH; Hancock, BW; Haybittle, JL; Linch, DC; MacLennan, KA; Vaughan Hudson, B; Vaughan Hudson, G1
Bellmunt, J; Bodi, R; Jolis, L; Mur, E; Navarro, M; Rubio, D; Solé, LA1
Chabner, BA1
Battifora, H; Moncada, A; Purdy, LJ; Sheibani, K; Stroup, RM1
Chang, SC; Hsu, JR; Perng, RP1
Cossman, J; DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wesley, MN1
Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S1
Connors, JM; Hoskins, P; Klimo, P; O'Reilly, SE1
DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Miller, TP; Young, RC1
Bourstyn, E; Brice, P; Colin, P; D'Agay, MF; Extra, JM; Fermand, JP; Fermé, C; Frija, J; Lepage, E; Miclea, JM1
Brack, N; Brittinger, G; Dornoff, W; Engelhard, M; Enne, W; Gassmann, W; Gerhartz, H; Hallek, M; Heise, J; Meusers, P1
Capnist, G; Chisesi, T; Contu, A; Coser, P; Porcellini, A; Rancan, L; Rizzoli, V; Salvagno, L; Santini, G; Sertoli, M1
Andreopoulos, D; Glöckner, WM; Klose, KC1
Bastion, Y; Coiffier, B; Tigaud, JD1
Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R1
Carrión, JR; Delgado, JR; Dominguez, S; Flores, E; Garcia, P; Jaen, J; Santos, JA1
Feig, SA; Harris, R; Matthay, KK; Moss, TJ; Ramsay, N; Reynolds, CP; Seeger, RC; Selch, M; Villablanca, JG1
Horiguchi, T; Kawahara, S; Kiura, K; Mima, Y; Moritaka, T; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yonei, T1
Calogero, JA; Hellman, RM; Kaplan, BM1
Cellerino, R; Dazzi, C; Guidi, F; Isidori, P; Rossi, A; Torresi, U; Tummarello, D1
Debranin, CO1
Chao, NJ; Horning, SJ; Rosenberg, SA1
Bron, D; Stryckmans, P; Vandenheule, B1
Bonadonna, G; Bonfante, V; Santoro, A; Valagussa, P; Viviani, S2
Bonadonna, G; Santoro, A; Valagussa, P1
DeVita, VT2
Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K1
Daly, PA; Finn, T; Lawlor, E; O'Briain, DS; O'Brien, AA; Rogers, FM; Ward, R1
Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD1
Cossman, J; Glatstein, E; Lawrence, TS; Steinberg, SM; Sundeen, JT; Urba, WJ; Young, RC1
Brittinger, G; Dörken, B; Engelhard, M; Engert, W; Enne, W; Fuchs, R; Gerhartz, HH; Hagen-Aukamp, CH; Huhn, D; Thiel, E1
Brittinger, G; Engelhard, M; Gerhartz, H; Heinz, R; Huhn, D; Meusers, P; Neubauer, A; Siegert, W; Stacher, A; Thiel, E1
DeVita, VT; Glatstein, E; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC1
Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G1
Bladé, J; Cervantes, F; Montserrat, E; Reverter, JC; Rozman, C1
Brittinger, G; Engelhard, M; Gerhartz, HH; Heinz, R; Huhn, D; Meusers, P; Siegert, W; Stacher, A; Thiel, E; Wilmanns, W1
Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN1
Goto, S; Hotta, T; Ichikawa, A; Inoue, C; Murate, T; Nagura, E; Ninomiya, N; Ohnishi, K; Tsushita, K; Utsumi, M1
Anders, C; Höffken, K; Meier, CR; Nowrousian, MR; Osieka, R; Schmidt, CG; Schoetensack, B1
Hiraki, S; Kawahara, S; Kiura, K; Kozuka, A; Nishii, K; Numata, T; Ohnoshi, T; Ueoka, H; Yamashta, H; Yonei, T1
Adamo, V; Alafaci, E; Altavilla, G; Buemi, B; Caristi, N; Condemi, G; Toscano, G1
DeVita, VT; Fisher, RI; Longo, D; Young, RC1
DeVita, VT; Duffey, PL; Fisher, RI; Gilliom, M; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Young, RC1
Arriagada, R; Baume, D; Beaujean, F; Gouyette, A; Hayat, M; Le Chevalier, T; Ostronoff, M; Pico, JL; Rebattu, P1
Bandou, H; Doi, H; Fukuta, K; Kinoshita, S; Matsuura, A; Nakamura, T; Ogura, T; Shimizu, E; Yamasaki, K; Yamashita, T1
Cellerino, R; Guidi, F; Isidori, P; Porfiri, E; Raspugli, M; Tummarello, D1
Ardizzoni, A; Canobbio, L; Carbone, A; Franceschi, S; Magri, MD; Mazza, F; Rosso, R; Talamini, R; Tirelli, U; Veronesi, A1
Livingston, RB1
Chak, LY; Cox, RS; Kushlan, PD; Porzig, KJ; Sikic, BI; Wasserstein, P; Zatz, LM1
Barkley, HT; Benjamin, RS; Bodey, GP; Frankmann, C; Jeffries, DG; McMurtrey, MJ; Murphy, WK; Valdivieso, M; Welch, SR1
Creech, RH; Ettinger, DS; Finkelstein, DM; Joss, RA; Mason, BA; Ruckdeschel, JC; Vogl, S1
Ettinger, DS; Finkelstein, DM; Ruckdeschel, JC1
Hodson, DI; Levitt, M; Malaker, K; Meikle, AL1
Barlogie, B; Cabanillas, F; Freireich, EJ; Keating, M1
Aisner, J; Van Echo, DA; Whitacre, M; Wiernik, PH1
Boutin, P; Carcassone, Y; Cupissol, D; Michel, FB; Plagne, R; Serrou, B1
Antic, R; Drew, MJ; Gill, PG; McLennan, G; Robinson, PC1
Barkley, HT; Bodey, GP; Burgess, MA; Cabanillas, F; Chen, T; Frazier, H; Keating, M; Murphy, WK; Valdivieso, M1
Berard, C; DeVita, VT; Fisher, RI; Hubbard, SM; Jaffe, E; Longo, DL; Wesley, M; Young, RC1
Chabner, BA; DeVita, VT; Fisher, RI; Hubbard, SM; Longo, DL; Wesley, R; Young, RC1
Brennan, MF; Fisher, RI; Popp, MB; Simon, RM1
Barkley, HT; Benjamin, RS; Bodey, GP; Ertel, M; Freeman, MB; Mountain, CF; Smith, TL; Valdivieso, M1
Dalal, BI; Heyman, M; Horsman, D; Kidd, P; Kingreen, D; Loughran, TP; Phillips, GL1
Blackledge, GR; Child, JA; Cullen, MH; Fletcher, J; Grieve, RJ; Jones, EL; Murphy, A; Stuart, NS; Woodroffe, C1
Cabanillas, F; Hagemeister, FB; Lee, MS; McLaughlin, P; Pate, O; Rodriguez, MA; Romaguera, J; Sarris, A; Swan, F; Younes, A1
Bron, D; Carde, P; de Bock, R; De Wolf-Peeters, C; Delmer, A; Keunig, JJ; Keuning, JJ; Somers, R; Thomas, J; Tirelli, U1
Chan, T; Cooper, I; Januszewicz, E; Juneja, S; Wolf, M1
Chisesi, T; Congiu, AM; Contu, A; Coser, P; Porcellini, A; Rubagotti, A; Salvagno, L; Santini, G; Sertoli, MR; Vespignani, M1
Alessandrino, EP; Astori, C; Bernasconi, P; Brusamolino, E; Canevari, A; Castelli, G; Lazzarino, M; Morra, E; Orlandi, E; Pagnucco, G1
DeVita, VT; Duffey, PL; Fisher, RI; Hubbard, SM; Jaffe, ES; Longo, DL; Raffeld, M; Wittes, RE; Young, RC1
Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R1
Brittinger, G; Engelhard, M; Heinz, R; Huhn, D; Nerl, C; Parwaresch, R; Siegert, W; Tiemann, M1
Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A1
Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK1
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ1
Postmus, PE; Smit, EF1
Dreger, P; Haferlach, T; Klöss, M; Loeffler, M; Löffler, H; Petersen, B; Schmitz, N1
Carr, TJ; Costanzo, MR; Fisher, RI; Mullen, GM; Swinnen, LJ1
Bijnens, L; Hagenbeek, A; Kluin-Nelemans, JC; Meerwaldt, JH; Noordijk, EM; Peeters, CD; Pittaluga, S; Somers, R; Teodorovic, I; van Glabbeke, M1
Barcos, M; Canellos, GP; Duggan, DB; Peterson, BA; Petroni, GR1
Chen, DF; Sun, Y; Yin, WB; Zhang, DW; Zhang, RG; Zhang, XR1
Arnott, S; Crowther, D; Deakin, DP; Gupta, RK; James, RD; Oza, A; Radford, JA; Rohatiner, AZ; Ryder, WD; Wilkinson, PM1
Diehl, V1
Watkins, SM1
Hara, A; Niitsu, N; Shirai, T; Umeda, M1
Clark, ST; Crowther, D; Radford, JA; Shalet, SM; Swindell, R1
Brice, P; Castaigne, S; Gisselbrecht, C; Marolleau, JP; Pautier, P1
Broder, LE; Charyulu, KN; Donnelly, EJ; Rao, RK; Raub, WA; Saldana, MJ; Selawry, OS; Sridhar, KS1
Brown, AE; Crown, JP; Gulati, SC; Jurcic, JG; Koll, B; Yahalom, J1
Adams, JE; Clark, ST; Crowther, DC; Holmes, SJ; Shalet, SM; Whitehouse, RW1
Baxter, JD; DiNubile, MJ1
Fairey, AF; Jones, HW; Mead, GM; Sweetenham, JW; Whitehouse, JM1
Godwin, JE; Yuen, BH1
Anderson, L; Hancock, BW; Linch, DC; MacLennan, KA; Vaughan Hudson, B; Vaughan Hudson, G1
Blanchard, CG; Eastman, AY; McSharry, JJ; Pearce, T; Portuese, E; Powell, D; Remick, SC; Wagner, H; Wighton, T; Wolf, BC1
Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA1
Figueroa, M; Gehlsen, J; Hammond, D; McMillan, R; Ondreyco, S; Piro, L; Pomeroy, T; Williams, F1
Kamijima, S; Kato, Y; Kobayashi, H; Kuwahara, M; Mihara, H; Nagasaka, T; Oguri, T; Takeda, H1
Ben-Arieh, Y; Ben-Shahar, M; Epelbaum, R; Freidin, N; Haim, N; Leviov, M; Reshef, R1
Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H1
Bijnens, L; De Wolf-Peeters, C; Hagenbeek, A; Meerwaldt, JH; Noordijk, EM; Pittaluga, S; Somers, R; Teodorovic, I; Thomas, J1
Abdallah, JM; Kirsch, IR; Lombardi, DP1
Kumagai, K; Sakai, C; Takagi, T; Wakatsuki, S1
DaSilva, V; Dent, S; Eapen, L; Girard, A; Hugenholtz, H; Stewart, DJ1
Fisher, RI; Gaynor, ER1
Nishikawa, K1
Amigo, ML; Caballero, D; del Cañizo, C; Revilla, R; San Miguel, JF; Sánchez, C1
Raez, LE; Saldana, M; Temple, JD1
Cooper, DL; Levy, A; Salloum, E; Tallini, G1
Adler, M; Diehl, V; Hasenclever, D; Koch, P; Lathan, B; Lieberz, D; Loeffler, M; Pfreundschuh, M; Rüffer, U; Sieber, M; Tesch, H1
Aydemir, U; Bierwolf, S; Brittinger, G; Engelhard, M; Gerhartz, HH; Griesser, H; Huhn, D; Lennert, K; Meusers, P; Siegert, W; Thiel, E; Tiemann, M; Wilmanns, W1
Bezwoda, WR; Dansey, R; Davidge-Pitts, M1
Aranguren, PN; Ardaiz, MC; Bruno, S; Cancela, ME; Cerutti, I; Corrado, C; Dibar, E; Donato, H; Lastiri, F; Magnasco, H; Pavlovsky, S; Raslawski, E; Rosso, A; Salvarezza, A; Schvartzman, E; Zirone, S1
Bayle, C; Corti, C; Cosset, JM; Girinsky, T; Hayat, M; Nasr, F; Ribrag, V; Rougier, P; Theodore, C1
Alderete, D; Alfaro, E; Casak, S; Chantada, G; Felice, MS; Gallo, G; Quinteros, R; Sackmann-Muriel, F; Scopinaro, M; Zubizarreta, P1
Adams, G; Flynn, P; Grunnet, M; Hellman, R; Karp, D; Neuberg, DS; Robins, HI; Wagner, H1
Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S1
Bairey, O; Blickstein, D; Epstein, O; Gabbay, U; Lahav, J; Prokocimer, M; Shaklai, M; Stark, P1
Anderson, S; Dunlop, DJ; Eatock, MM; Fitzsimmons, EJ; Lucie, N; Paul, J; Reed, NS; Soukop, M; Steward, WP; Tansey, P1
Brämswig, JH; Gerres, L; Jürgens, H; Schellong, G; Schlegel, W1
Borsi, JD; Csáki, C; Ferencz, T; Horváth, J; Paál, K; Schuler, D1
Bruntsch, U; Diehl, V; Dölken, G; Engert, A; Franklin, J; Hasenclever, D; Koch, P; Lathan, B; Loeffler, M; Müller, U; Pfreundschuh, M; Rüffer, U; Schalk, KP; Schmitz, N; Schwieder, G; Sieber, M; Tesch, H; Tirier, C; Worst, P; Wulf, G1
Bischoff, H; Diehl, V; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rueffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G1
Shimoyama, M; Tsushita, K; Utsumi, M1
Dobashi, N; Kuraishi, Y; Usui, N1
Bischoff, H; Diehl, V; Dühmke, E; Engert, A; Franklin, J; Georgii, A; Glunz, A; Haedicke, C; Hasenclever, D; Hermann, R; Holmer, L; Krause, S; Lathan, B; Loeffler, M; Paulus, U; Pfreundschuh, M; Rüffer, JU; Sextro, M; Sieber, M; Stappert-Jahn, U; Tesch, H; von Kalle, K; Winnerlein-Trump, E; Wolf, J; Wulf, G1
Diehl, V; Hasenclever, D; Loeffler, M1
Schellong, G1
Cavalli, F; Gueneau, M; Martinelli, G; Peccatori, F; Saletti, P; Zucca, E1
Brocchieri, A; Grignani, G; Maiolo, A; Merlo, EM; Tua, A1
Benboubker, L; Bout, M; Cartron, G; Colombat, P; Delain, M; Lamagnere, JP; Linassier, C1
Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D1
Chastagner, P; Chouffai, Z; Couanet, D; Doireau, V; Grignon, Y; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Marchal, JC; Zerah, M1
Keyaki, A; Nabeshima, S; Waga, S1
Foss, HD; Keilholz, U; Knauf, W; Siehl, J; Szelényi, H; Thiel, E1
Balcerzak, SP; Dana, BW; Fisher, RI; Forman, JD; Gaynor, ER; Kjeldsberg, C; LeBlanc, M; Miller, T; Roy, V; Unger, JM1
Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP1
Cabanillas, F1
Diehl, V; Engel, C; Loeffler, M; Schmitz, S; Tesch, H1
Chastagner, P; Couanet, D; Doz, F; Edan, C; Frappaz, D; Gambarelli, D; Gentet, JC; Grill, J; Habrand, JL; Kalifa, C; Le Deley, MC; Pierre-Kahn, A; Raquin, MA1
Janjindamai SHirunpat, S; Maipang MVasiknanonte, P1
Blanchard, CG; Dezube, BJ; Haase, RF; Mastrianni, DM; Nazeer, T; Ramnes, CR; Remick, SC; Sedransk, N1
Bayer, R; Cairncross, G; Forsyth, P; Hu, W; Kaminer, L; Macdonald, D; Paleologos, N; Peterson, K; Ramsay, D; Rosenfeld, S; Salzman, D; Smith, A; Stewart, D; Swinnen, L1
Bessell, EM; Burton, A; Cullen, MH; Gregory, WM; Hancock, BW; Hudson, GV; Jack, A; Linch, DC; Maclennan, KA; Selby, P; Smith, P1
Ansén, S; Bischoff, S; Bohlen, H; Diehl, V; Dietlein, M; Re, D; Scheidhauer, K; Schicha, H; Tesch, H; Weihrauch, MR; Wolf, J1
Chao, TY; Chen, YC; Ho, CL; Hwang, JM; Kao, WY; Sheu, LF1
Bethe, U; Cornely, OA; Pels, H; Ritzkowsky, A; Seibold, M; Soehngen, D; Toepelt, K1
Anselmo, AP; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Franklin, J; Georgii, A; Greil, R; Hasenclever, D; Herrmann, R; Josting, A; Kirchner, H; Koch, P; Koch, T; Lathan, B; Loeffler, M; Munker, R; Paulus, U; Pfistner, B; Pfreundschuh, M; Rueffer, U; Schalk, KP; Sieber, M; Tesch, H; Wolf, J1
Carde, P; Cavalli, F; Diehl, V; Franklin, J1
Diehl, V; Glossmann, JP; Josting, A1
Hutchinson, RJ; Kelly, KM; Lones, MA; Massey, V; Perkins, SL; Sposto, R; Weiner, MA1
Diehl, V; Franklin, J1
Barbui, T; Chang, J; Cowan, RA; Crowther, D; Deakin, DP; Dunlop, DJ; Gupta, RK; James, RD; Lister, TA; Lucie, NP; Radford, JA; Rohatiner, AZ; Rossi, A; Ryder, WD; Shamash, J; Wilkinson, PM1
Ayala, A; Cabanillas, F; Hagemeister, FB; Hess, M; Lee, MS; McLaughlin, P; Preti, A; Rodriguez, MA; Romaguera, J; Sarris, A; Smith, TL; Tsimberidou, AM; Yang, Y; Younes, A1
Jereb, B; Macedoni-Luksic, M; Todorovski, L1
Boissevain, F; Bredenfeld, H; Diehl, V; Eich, H; Engert, A; Franklin, J; Josting, A; Koch, P; Koch, T; Müller-Hermelink, HK; Naumann, R; Paulus, U; Reineke, T; Rueffer, U; Sieber, M; Soekler, M; Wolf, J; Worst, P1
Griniūte, R; Pileckyte, M1
Diehl, V; Dörken, B; Dühmke, E; Franklin, J; Hasenclever, D; Herrmann, R; Lathan, B; Loeffler, M; Müller-Hermelink, HK; Paulus, U; Pfreundschuh, M; Tesch, H1
Dervenoulas, J; Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Kalantzis, D; Papageorgiou, S; Raptis, S; Xiros, N1
Ekert, H1
Diehl, V; Franzen, C; Hartmann, P; Rehwald, U; Salzberger, B; Sieber, M; Wöhrmann, A1
Dekker, AW; Mandigers, CM; Meijerink, JP; Raemaekers, JM; Schattenberg, AV; Verdonck, LF1
Adamo, F; Ambrosetti, A; Angelucci, E; Anselmo, AP; Bertini, M; Boccadoro, M; Cavalieri, E; Gallo, E; Gavarotti, P; Genua, A; Levis, A; Liberati, M; Mandelli, F; Pavone, V; Pietrasanta, D; Ricetti, MM; Salvi, F; Scalabrini, DR; Vitolo, U1
Arima, N; Arimura, K; Hamada, H; Kukita, T; Matsushita, K; Tei, C1
Hehn, ST; Miller, TP1
Bischof, H; Brosteanu, O; Diehl, V; Doelken, G; Duehmke, E; Engert, A; Fischer, R; Georgii, A; Glunz, A; Greil, R; Hansmann, ML; Hasenclever, D; Hermann, R; Koch, B; Koch, P; Loeffler, M; Mueller, RP; Munker, R; Oertel, J; Paulus, U; Pfistner, B; Roller, S; Rueffer, U; Schalk, KP; Schober, T; Sieber, M; Stein, H; Tesch, H; von Kalle, K; Willich, N; Worst, P1
Cowan, RA; Deakin, DP; Harris, MA; James, RD; Radford, JA; Swindell, R1
Abrey, LE; DeAngelis, LM; Lai, R; Rosenblum, MK1
Diehl, V; Eich, HT; Engert, A; Franklin, J; Gossmann, A; Hansemann, K; Josting, A; Kocher, M; Krug, B; Müller, RP; Semrau, R; Skripnitchenko, R; Staar, S1
Brosteanu, O; Diehl, V; Hasenclever, D; Loeffler, M1
Bredenfeld, H; Diehl, V; Engert, A; Franklin, J; Fries, S; Josting, A; Mailänder, V; Nogova, L; Oertel, J1
Calabrese, L; Cavalli, F; Cocorocchio, E; Ghielmini, M; Martinelli, G; Mazzetta, C; Pastano, R; Peccatori, F; Pruneri, G; Saletti, PC; Zucca, E1
Bourg, V; Chanalet, S; Chatel, M; Fontaine, D; Frenay, M; Lebrun, C; Lonjon, M; Michiels, JF; Paquis, P; Ramaioli, A; Vandenbos, F1
Illés, A1
Bain, BJ; Chakravorty, S; Coulter, C; Johnston, R1
Ballova, V; Diehl, V; Dühmke, E; Eich, HT; Engert, A; Haverkamp, H; Hentrich, M; Josting, A; Löffler, M; Müller-Hermelink, HK; Naumann, R; Pfistner, B; Rüffer, JU; Wilhelmy, M; Worst, P1
Boettcher, HD; Diehl, V; Eich, HT; Engert, A; Franklin, J; Glossmann, JP; Josting, A; Müller, RP; Nogová, L; Schober, T; Schulz, U; Sieber, M1
Deák, B; Eid, H; Esik, O; Horváth, A; Horváth, GI; Keresztes, S; Lengyel, Z; Lovey, J; Molnár, Z; Rosta, A; Schneider, K; Schneider, T; Tóth, E; Várady, E1
Hondoh, H; Morii, K; Onda, K; Shinbo, Y; Takahashi, H; Takeuchi, S; Tamura, T; Tanaka, R; Yamanaka, R1
Illés, A; Molnár, Z; Udvardy, M1
Connors, JM4
Cabanillas, F; Cox, JD; Ha, CS; Lee, MS; McLaughlin, P; Mesina, OM; Rodriguez, MA; Romaguera, JE; Tucker, SL; Younes, A1
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U1
Fisher, RI; LeBlanc, M; Maloney, DG; Miller, TP; Press, OW; Unger, JM1
Behringer, K; Breuer, K; Diehl, V; Engert, A; Klimm, B; May, M; Nogova, L; Reineke, T; Schmitz, T; Wildt, L1
Ballova, V; Diehl, V; Franklin, J; Glossmann, J; Josting, A; Nogova, L; Rüffer, JU; Sieber, M1
Bartlett, NL2
Clawson, S; Cullen, MH; Hancock, BW; Jack, AS; Johnson, PW; MacLennan, KA; Radford, JA; Ryder, D; Smith, P; Stenning, SP; Sydes, MR; Walewski, J1
Fukuda, H; Fukuhara, S; Hirose, Y; Hotta, T; Kawano, F; Kikuchi, M; Mizoroki, F; Nakata, M; Nasu, K; Ohno, Y; Sano, M; Sawada, K; Shimoyama, M; Taniwaki, M; Tobinai, K; Togawa, A; Toki, H; Uozumi, K1
Bacon, P; Berger, D; Bredenfeld, H; Diehl, V; Döhner, H; Easton, V; Engert, A; Ho, AD; Schmitz, N; Skacel, T1
Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ1
Fu, P; Mwanda, WO; Ness, A; Orem, J; Remick, SC1
Bohlius, J; Engert, A; Hülsewede, H; Kober, T1
Diehl, V; Engert, A1
Elbl, L; Jedlicka, F; Kral, Z; Smardova, L; Tomaskova, I; Vasova, I; Vorlicek, J; Wagnerova, B1
Björkholm, M; Celsing, F; Johansson, E1
Gospodarowicz, MK; Heaton, R; Hodgson, DC; Koh, ES; Pintilie, M; Sun, A; Tran, TH; Tsang, R; Wells, W1
Chastagner, P; Doz, F; Dufour, C; Frappaz, D; Gentet, JC; Grill, J; Kalifa, C; Lellouch-Tubiana, A; Pichon, F; Plantaz, D; Puget, S; Raquin, MA1
Corrado, C; Greco, M; Niccodemi, C; Presas, J; Valsecchi, M; Winkel, M1
Avivi, I; Bar-Shalom, R; Ben-Shachar, M; Dann, EJ; Epelbaum, R; Goor, O; Haim, N; Kirschbaum, M; Libster, D; Rowe, JM; Tamir, A; Zuckerman, T1
Lowinger, JS; Pearson, S-; Ringland, C; Stark, H; Tan, EL; Ward, R1
Akalan, N; Akyüz, C; Atahan, L; Büyükpamukçu, M; Kutluk, T; Selek, U; Söylemezoglu, F; Varan, A; Yalçin, B1
Aoki, S; Hirano, M; Miura, I; Niitsu, N; Okamoto, M; Tamaru, J; Tomita, N1
Behringer, K; Diehl, V1
Busse, D; Diehl, V; Engert, A; Fuhr, U; Hempel, G; Jaehde, U; Jetter, A; Josting, A; Kasel, D; Klimm, B; Merkel, U; Reif, S; Rietbrock, S; Schwab, M; Wilde, S1
Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L1
Homma, J; Hondoh, H; Morii, K; Onda, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Bredenfeld, H; Brillant, C; Diehl, V; Eich, HT; Engert, A; Gossmann, A; Hansemann, K; Kriz, J; Müller, RP; Pfistner, B; Skripnitchenko, R; Staar, S1
Al-Ali, HK; Niederwieser, D; Wittekind, C1
Diehl, V; Fuchs, M1
Bredenfeld, H; Diehl, V; Eich, HT; Engert, A; Macann, A; Müller, RP1
Diehl, V; Engert, A; Josting, A; Nogova, L; Pfistner, B; Reineke, T; Sieniawski, M1
Horning, SJ1
Wedgwood, A; Younes, A1
Coleman, M; Elstrom, R; Furman, R; George, P; Kaufmann, T; Leonard, J; Martin, P; Niesvizky, R; Ruan, J1
Ansell, S; Arndt, C; Buckner, J; Christianson, T; Galanis, E; Gill, P; Litzow, M; Moynihan, T1
Coleman, M; Elstrom, R; Furman, R; George, P; Kaufman, TP; Leonard, JP; Martin, P; Niesvizky, R; Ruan, J1
Dickhuth, HH; Hirschberger, B; Muser, K; Pottgiesser, T; Roecker, K; Schumacher, YO1
Homma, J; Hondoh, H; Kakuma, T; Morii, K; Sano, M; Shinbo, Y; Takahashi, H; Tamura, T; Tanaka, R; Tsuchiya, N; Yajima, N; Yamanaka, R1
Filatova, LV2
Behringer, K; Diehl, V; Engert, A; Fuchs, M; Halbsguth, T; Josting, A; Nogova, L; Reineke, T; Sieniawski, M1
Ashley, DM; Dobrovic, A; Drummond, KJ; Friedman, HS; Gan, HK; Hawkins, CJ; Johns, TG; Kaye, AH; Lovric, MM; Maxwell, JA; Mikeska, T; Riffkin, CD1
Diehl, V; Evens, AM; Hutchings, M1
Amthauer, H; Bares, R; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Eich, HT; Engert, A; Franklin, J; Fuchs, M; Klutmann, S; Knapp, WH; Kobe, C; Lohri, A; Lorenz, R; Markova, J; Mueller, RP; Schicha, H; Schreckenberger, M; Weckesser, M; Zijlstra, JM1
Dzhulakian, UL; Egorova, EK; Giliazitdinova, EA; Gorgidze, LA; Kaplanskaia, IB; Krasil'nikova, BB; Kravchenko, SK; Kremenetskaia, AM; Lutsenko, IN; Magomedova, AU; Mar'in, DS; Margolin, OV; Ryzhikova, NA; Samoĭlova, RS; Valiev, TT; Vinogradova, IuE; Vorob'ev, AI; Vorob'ev, IA; Zvonkov, EE1
Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A1
Hamaguchi, H; Kato, A; Mikoshiba, M; Nagata, K; Nakane, M; Takano, H1
Angrilli, F; Baldini, L; Brugiatelli, M; Cervetti, G; Di Renzo, N; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Luminari, S; Marcheselli, L; Mazza, P; Merli, F; Montanini, A; Musto, P; Polimeno, G; Pozzi, S; Scalone, R; Stelitano, C1
Dedeckova, K; Dietlein, M; Eich, HT; Engert, A; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Plütschow, A; Skopalova, M1
Brugiatelli, M; Danova, M; Federico, M; Gentile, M; Gobbi, PG; Iannitto, E; Luminari, S; Mammi, C; Merli, F; Morabito, F; Quintana, G; Rovati, B; Stelitano, C; Valentino, F1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S1
Abdallah, FK; Ayers, LW; Bako, J; Banura, C; Black, J; Fu, P; Johnson, JL; Kakembo, J; Katongole-Mbidde, E; Lederman, MM; Meyerson, HJ; Mwanda, WO; Ness, A; Onyango, CA; Orem, J; Remick, SC; Reynolds, S; Subbiah, V; Wabinga, H; Whalen, CC1
von Bergwelt-Baildon, MS; Weihrauch, MR1
Avigdor, A; Ben-Bassat, I; Bulvik, S; Dann, EJ; Levi, I; Nagler, A; Perez-Avraham, G; Polliack, A; Shemtov, N; Shimoni, A1
Aulitzky, WE; Bentz, M; Diehl, V; Dörken, B; Engert, A; Franklin, J; Hänel, M; Hasenclever, D; Koch, P; Löffler, M; Lohri, A; Ludwig, WD; Müller-Hermelink, HK; Pfreundschuh, M; Rummel, M; Sezer, O; Trümper, L; Wilhelm, M1
Domm, J; Eckrich, MJ; Frangoul, H; Ho, R; Whitlock, JA1
Annechini, G; Cavalieri, E; De Angelis, F; Foà, R; Frattarelli, N; Gentilini, F; Grapulin, L; Mandelli, F; Matturro, A; Pulsoni, A; Sacco, M; Torelli, F; Vignetti, M1
Eichenauer, DA; Engert, A1
Adler, G; Bommer, M; Dikopoulos, N; Klaus, J; Kleger, A; Kunze, M; Leithaeuser, F; Wegener, M1
García-Sanz, R; González-López, TJ; Graciani, IF; Hermida, G; San Miguel, JF; Vázquez, L1
Bonetti, E; Dondi, A; Falorio, S; Federico, M; Gobbi, PG; Merli, F; Quarta, G; Rosti, V; Stelitano, C; Valentino, F1
Kuruvilla, J1
Cheung, K; Coleman, M; Elstrom, R; Faye, A; Furman, RR; Hajjar, KA; Lachs, M; Leonard, JP; Martin, P; Ruan, J1
Behringer, K; Borchmann, P; Diehl, V; Engert, A; Ganitis, P; Hofer, S; Mattle, V; Mueller, H; Ott, HW; Pluetschow, A; van den Hoonaard, B; Wildt, L1
Borchmann, P; Diehl, V; Engert, A; Flechtner, HH; Fuchs, M; Haverkamp, H; Josting, A; Lohri, A; Nogova, L; Rank, A; Sökler, M; Sturm, I; Topp, MS; Villalobos, M; Vogelhuber, M; Zenz, T; Zijlstra, J1
Cheson, BD2
Abla, O; Trakymiene, SS1
Bauer, K; Brillant, C; Engert, A; Herbst, C; Kluge, S; Monsef, I; Skoetz, N1
Fesler, MJ; Nguyen, NC; Petruska, PJ1
Bergsträsser, E; Dieckmann, K; Dörffel, W; Fosså, A; Hasenclever, D; Hummel, M; Karlén, J; Klapper, W; Kluge, R; Körholz, D; Mann, G; Mauz-Körholz, C; Pelz, T; Ruschke, K; Stein, H; Stiefel, M; Vilser, C; Voigt, A; Vordermark, D; Winkler, M1
Borchmann, P; Debus, J; Diehl, V; Döhner, H; Dörken, B; Eich, HT; Engert, A; Görgen, H; Greil, R; Grosu, AL; Ho, A; Karstens, JH; Markova, J; Müller, RP; Müller-Hermelink, HK; Pabst, T; Rank, A; Schmidberger, H; Wiegel, T; Willich, N1
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M1
Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S1
Hutchinson, R; Kelly, KM; Lones, M; Massey, V; McCarten, K; Perkins, S; Sposto, R; Villaluna, D; Weiner, M1
Barrington, S; Biggi, A; Cantonetti, M; Chauvie, S; Di Raimondo, F; Fallanca, F; Feldman, T; Ficola, U; Fiore, F; Gallamini, A; Gavarotti, P; Gianni, AM; Leone, M; Mulè, A; Patti, C; Rambaldi, A; Rossi, A; Sorasio, R; Stelitano, C; Viviani, S1
Bartels, U; Bouffet, E; Dirks, P; Fried, I; Hawkins, C; Huang, A; Scheinemann, K; Tabori, U; Tsangaris, E1
Homma, C; Miwa, A; Sekiguchi, N; Shikai, T; Takezako, N; Takezako, Y; Tanimura, A; Yamagata, N1
Straus, DJ1
Böll, B; Dedeckova, K; Dietlein, M; Eich, HT; Kahraman, D; Klaskova, K; Kobe, C; Kozak, T; Markova, J; Mocikova, H; Skopalova, M1
Bonadonna, G; Bonfante, V; Brusamolino, E; Gallamini, A; Gianni, AM; Gotti, M; Levis, A; Liberati, AM; Pogliani, EM; Pregno, P; Pulsoni, A; Rambaldi, A; Rossi, A; Rota Scalabrini, D; Specchia, G; Valagussa, P; Vitolo, U; Viviani, S; Zaja, F; Zinzani, PL1
Bauer, K; Brillant, C; Engert, A; Monsef, I; Skoetz, N1
Johnson, PW; Lim, SH1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT1
Aurlien, E; Blystad, AK; Fiskvik, IH; Fosså, A; Hole, KH; Holte, H; Ikonomou, IM; Kolstad, A; Lauritzsen, GF1
Avivi, I; Bar-Shalom, R; Ben-Shachar, M; Blumenfeld, Z; Dann, EJ; Epelbaum, R; Gaitini, D; Goor, O; Libster, D; Rowe, JM1
Brown, JB; Kadoyama, K; Kuwahara, A; Okuno, Y; Sakaeda, T; Yamamori, M1
Borchmann, P; Diehl, V; Engert, A1
Borchmann, P; Cerny, T; Diehl, V; Dörken, B; Eich, HT; Engert, A; Fuchs, M; Greil, R; Haverkamp, H; Ho, AD; Huber, C; Kanz, L; Krause, SW; Markova, J; Mueller, RP; Mueller-Hermelink, HK; Nerl, C; Paulus, U; Rank, A; Smardova, L1
Ardeshna, K; D'Sa, S; Marzolini, M; Padhani, A; Wong, WL1
Baybay, H; Berrady, R; Bono, W; El Hatimi, A; Gallouj, S; Khammar, Z; Lahlou, M; Lamchachti, L; Mernissi, FZ1
Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Thielen, I; van der Ven, K; von Wolff, M1
Borchmann, P; Diehl, V; Eich, HT; Engert, A; Fuchs, M; Greil, R; Klimm, B; Kral, Z; Lohri, A; Markova, J; Meissner, J; Mueller, RP; Plütschow, A; Soekler, M; Stein, H; Topp, MS; von Tresckow, B; Zijlstra, JM1
Bruessow, C; Gubler, J; Karrer, U; Pless, M1
Casasnovas, O; Coiffier, B1
Amthauer, H; Andreesen, R; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Döhner, H; Dörken, B; Eich, HT; Engel, N; Engert, A; Fuchs, M; Greil, R; Hallek, M; Haverkamp, H; Ho, A; Kanz, L; Kluge, R; Klutmann, S; Kneba, M; Kobe, C; Král, Z; Kratochwil, C; Markova, J; Müller, RP; Pfreundschuh, M; Renner, C; Schober, O; Stein, H; Topp, M; Zijlstra, J1
Coleman, M; Elstrom, RL; Leonard, JP; Martin, P; Ruan, G1
Kuruvilla, J; Uhm, J1
Akalan, N; Akyüz, C; Balcı, S; Batu, A; Büyükpamukçu, M; Cila, A; Kutluk, T; Soylemezoğlu, F; Varan, A; Zorlu, F1
Papavassiliou, P; Sebastian, S; Wang, E1
Datsenko, PV; Evstikheev, ÉV; Golub, SV; Gombolevskiĭ, VA; Ivashin, AV; Pan'shin, GA; Sotnikov, VM3
Filatova, LV; Gershanovich, ML; Semiglazova, TIu; Tarasenkova, AA1
Huang, JJ; Jiang, WQ; Li, ZM; Xia, Y; Zhu, YJ1
Bargetzi, M; Cairoli, A; Cerutti, A; Heim, D; Hess, U; Lerch, E; Pabst, T; Renner, C; Samaras, P; Wannesson, L; Zucca, E1
Filatova, LV; Gershanovich, ML; Semiglazov, TIu; Tarasenkova, AA1
Casini, M; Cavattoni, IM; Cortelazzo, S; Deola, S; Farsad, M; Mian, M; Pescosta, N1
Hwang, W; Lee, YS; Phipps, C1
Bauer, K; Engert, A; Hübel, K; Monsef, I; Rancea, M; Skoetz, N1
Baudry, G; Dechambre, S; Delcourt, A; Doyen, C; Malvaux, P; Oriot, P; Rousseau, E; Waignein, F1
Brown, JM; Fan, AC; Felsher, DW; Fischbein, NJ; Howard, W; Hsieh, RW; McClellan, JS; To, CA1
Alt, J; Arasteh, K; Berger, M; Engert, A; Fätkenheuer, G; Hentrich, M; Hoffmann, C; Mosthaf, F; Müller, M; Nickelsen, M; Planker, M; Rieke, A; Rockstroh, JK; Schmidmaier, R; Schürmann, D; Seidel, E; Siehl, J; Wolf, T; Wyen, C1
Giza, A; Jurczak, W; Krochmalczyk, D; Skotnicki, AB; Sobociński, M1
Barsaoui, S; Bel Hadj Ali, Z; Belaid, I; Ben Romdhane, N; Fdhila, F; Kochbati, L; Maalej, M; Mezlini, A; Oubich, F; Rifi, H1
Behringer, K; Borchmann, P; Diehl, V; Eibl, AD; Engert, A; Fuchs, M; Goergen, H; Halbsguth, T; Kuehr, M; Mueller, H; Reiners, KS; Renno, JH; Rosenbrock, J; Schober, T; Stumpf, V; Thielen, I; van der Ven, K; von Wolff, M; Wessels, C; Wiehlpütz, M1
Kravchenko, SK; Moiseyeva, TN; Sharkunov, NN; Vinogradova, OY; Zybunova, EE1
Campr, V; Kozak, T; Mocikova, H; Palickova, M; Vernerova, Z1
Burger, IA; Goldman, DA; Gonen, M; Hricak, H; Kumar, A; Schöder, H; Vargas, HA; Zelenetz, AD1
Albrecht, M; Bökkerink, J; Claviez, A; Dörffel, W; Holte, H; Karlen, J; Lüders, H; Mann, G; Marciniak, H; Niggli, F; Pötter, R; Rühl, U; Schellong, G; Schmiegelow, K; Schwarze, EW; Wickmann, L1
Borchmann, P; Kreissl, S1
Aulitzky, W; Borchmann, P; Diehl, V; Dührsen, U; Engert, A; Fuchs, M; Hertenstein, B; Klimm, B; Lindemann, W; Maschmeyer, G; Plütschow, A; Sasse, S; Vieler, T; Wongso, D1
Filatova, LV; Gershanovich, ML; Plotnikova, AA; Semiglazova, TIu1
Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A1
Engert, A; von Tresckow, B1
Borchmann, P; Diehl, V; Engert, A; Haverkamp, H; Rancea, M; Skoetz, N; Trelle, S1
Cao, H; Weber, R; Yamamoto, K; Yang, LX1
Borchmann, P1
Ansell, SM1
Danielewicz, I; Leśniewski-Kmak, K; Małkowski, B; Zalewska, M; Zaucha, JM; Zaucha, R1
Canellos, GP; Devita, VT; Friedberg, JW; Lister, TA; Rosenberg, SA1
Behringer, K; Böll, B; Borchmann, P; Diehl, V; Eichenauer, DA; Engert, A; Franklin, J; Fuchs, M; Halbsguth, T; Haverkamp, H; Klimm, B; Rothe, A; Sasse, S; Thielen, I; von Tresckow, B1
Barbaud, A; Bursztejn, AC; Cribier, B; Cuny, JF; Levy, E; Schmutz, JL; Schoeffler, A; Weinborn, M1
Abruzzese, E; André, MP; Bardet, S; Bellei, M; Bouabdallah, R; Brice, P; Brusamolino, E; Casasnovas, RO; Federico, M; Fermé, C; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Lievens, Y; Lugtenburg, PJ; Meignan, M; Morschhauser, F; Olivier, P; Oumedaly, R; Raemaekers, JM; Raveloarivahy, T; Re, A; Sebban, CJ; Stamatoullas, A; van der Borght, T; van der Maazen, R; van Imhoff, G; Versari, A1
Hallén, K; Molin, D; Nilsson, T; Nordgren, H; Sangfelt, P; Wanders, A1
Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A1
Amthauer, H; Bockisch, A; Borchmann, P; Diehl, V; Dietlein, M; Drzezga, A; Eich, HT; Engert, A; Franke, M; Fuchs, M; Haverkamp, H; Kahraman, D; Kluge, R; Klutmann, S; Kobe, C; Kuhnert, G; Maintz, D; Persigehl, T; Wolf, HH1
Battegay, M; Krasniqi, F; Kurz, M; Marzolini, C; Stoeckle, M1
Andre, M; Aoudjhane, A; Bachy, E; Bologna, S; Brice, P; Briere, J; Carde, P; Casasnovas, O; Colin, P; Delmer, A; Devidas, A; Gabarre, J; Gaillard, I; Heczko, M; Humbrecht, C; Jaubert, J; Mounier, N; Nicolas-Virelizier, E1
Nagai, H1
Belada, D; Smolej, L; Štěpánková, P; Sýkorová, A; Žák, P1
Brice, P; Briere, J; Deau, B; Franchi, P; Ohnona, J; Tamburini, J; Thieblemont, C1
Aujoulat, O; Boin, C; Fizesan, M; Ghergus, D; Lustig, H; Newinger, G; Ojeda-Uribe, M; Watier, H1
Ganesan, P; Ganesan, TS; Kannan, K; Krishnakumar, R; Lakshmipathy, KM; Mahajan, V; Radhakrishnan, V; Rajaraman, S; Rajendranath, R; Sagar, TG; Sundersingh, S; Udupa, K1
Dedecjus, M; Lech-Marańda, E; Pielaciński, K; Prochorec-Sobieszek, M; Szczepanik, AB; Warzocha, K1
Baues, C; Dietlein, M; Eich, HT; Engenhart-Cabillic, R; Engert, A; Haverkamp, H; Haverkamp, U; Hegerfeld, K; Herfarth, K; Kobe, C; Kriz, J; Kuhnert, G; Lukas, P; Reinartz, G; Schmidberger, H; Staar, S1
Advani, RH; Bartlett, NL; Blum, KA; Cheson, BD; Fisher, RI; Friedberg, JW; Gascoyne, RD; Gordon, LI; Habermann, TM; Hong, F; Hoppe, RT; Horning, SJ; Kahl, BS; Robinson, KS; Stewart, DA; Stiff, PJ; Tuscano, JM; Wagner, H1
Gallamini, A; Kostakoglu, L1
Datsenko, PV; Panshin, GA1
Bertozzi, AI; De Carli, E; Delion, M; Doz, F; Grill, J; Kalifa, C; Leblond, P; Rakotonjanahary, J; Rialland, X1
Böll, B; Borchmann, P; Diehl, V; Eichenauer, DA; Engert, A; Fuchs, M; Haverkamp, H; Sasse, S; von Tresckow, B1
Li, H; Liu, H; Qiu, L; Xiong, W; Yi, S; Zou, D1
Dong, F; Ke, X; Pang, Y; Wang, J1
Apel, A; Avigdor, A; Ben-Bassat, I; Dann, EJ; Davidson, T; Kedmi, M; Levi, I; Nagler, A; Polliack, A1
Boltežar, L; Jezeršek Novaković, B; Pintarić, K1
Annechini, G; Fiore, G; Gandini, L; Lenzi, A; Lombardo, F; Pallotti, F; Paoli, D; Pulsoni, A; Rizzo, F1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C1
Arakelyan, S; Avagyan, A; Bardakchyan, S; Danielyan, S; Hakobyan, L; Harutyunyan, L; Iskanyan, S; Safaryan, L; Sargsyan, L; Tamamyan, G; Voskanyan, A; Zohrabyan, D1
Barr, PM; Bartlett, NL; Cheson, BD; Cook, JR; Evens, AM; Fanale, MA; Fisher, RI; Friedberg, JW; Gascoyne, RD; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Lechowicz, MJ; Leonard, JP; Li, H; Mittra, ES; Moskowitz, CH; Noy, A; Press, OW; Rimsza, LM; Schöder, H; Straus, DJ; Sweetenham, JW1
Aurer, I; Bologna, S; Brice, P; Caillot, D; Carde, P; Casasnovas, O; Coiffier, B; Ferme, C; Fortpied, C; Gaillard, I; Glimelius, B; Karrasch, M; Khaled, H; Lugtenburg, PJ; Meyer, R; Morschhauser, F; Mounier, N; Seftel, M; Sureda, A; Wolf, M1
Bachanova, V; Boland, PJ; Eckfeldt, CE; Hegerova, LT; McKenna, RW; Williams, SJ1
Borchmann, S; Engert, A; von Tresckow, B1
Albano, D; Brancatelli, G; Galia, M; Grassedonio, E; La Grutta, L; Lagalla, R; Midiri, M; Mulè, A; Patti, C1
Johnson, PWM; Vassilakopoulos, TP1
Chen, G; Chen, Y; Huang, R; Jiang, Y1
Johnson, PW1
Cheson, BD; Kostakoglu, L1
Chong, G; Grigg, A; Hawkes, EA1
Bouaouina, N; Fourati, N; Kanoun Belajouza, S; Khlif, A; Regaieg, H1
André, MPE; Bellei, M; Bouabdallah, R; Brice, P; Casasnovas, O; Delarue, R; Edeline, V; Federico, M; Fermé, C; Fiaccadori, V; Fortpied, C; Girinsky, T; Gotti, M; Hutchings, M; Meignan, M; Merli, F; Raemaekers, J; Raveloarivahy, T; Re, A; Reman, O; Sebban, C; Specht, L; Stamatoullas, A; van der Maazen, R; van Imhoff, G; Versari, A1
Borchmann, P; Borchmann, S; Bröckelmann, PJ; Buerkle, C; Diehl, V; Engert, A; Fuchs, M; Goergen, H; Kreissl, S; Müller, H; Plütschow, A; Sasse, S1
Brillant, C; Engert, A; Monsef, I; Skoetz, N; von Tresckow, B; Will, A1
Abadi, U; Abdah-Bortnyak, R; Akria, L; Bairey, O; Bar-Shalom, R; Barzilai, E; Ben-Yehuda, D; Dann, EJ; Epelbaum, R; Filanovsky, K; Goldschmidt, N; Horowitz, NA; Kagna, O; Kornberg, A; Lavie, D; Mashiach, T; Paltiel, O; Ruchlemer, R; Shpilberg, O; Tadmor, T1
Anglaret, B; Audhuy, B; Bologna, S; Bouabdallah, R; Brice, P; Brière, J; Carde, P; Casasnovas, O; de Jong, D; de Weerdt, O; Delarue, R; Eghbali, H; Fermé, C; Henry-Amar, M; Janvier, M; Lugtenburg, PJ; Lybeert, MLM; Marjanovic, Z; Noordijk, EM; Raemaekers, JMM; Reman, O; Salles, G; Sebban, C; Spina, M; Tersteeg, RJHA; Thomas, J; Thyss, A; van Imhoff, GW; Vranovsky, A1
Jandial, A; Malhotra, P; Mishra, K; Nambiyar, K1
Bihl, M; Haefliger, S; Krasniqi, F; Tzankov, A1
Aulitzky, W; Baues, C; Beck, HJ; Bentz, M; Borchmann, P; Diehl, V; Dierlamm, J; Dietlein, M; Eich, H; Eichenauer, DA; Engert, A; Feuring-Buske, M; Fuchs, M; Goergen, H; Greil, R; Hertenstein, B; Hitz, F; Hüttmann, A; Keller, UB; Kobe, C; Kuhnert, G; Kühnhardt, D; Lohri, A; Ludwig, WD; Markova, J; Maschmeyer, G; Meissner, J; Ostermann, H; Pabst, T; Schmitz, N; Soekler, M; Stein, H; Topp, MS; Vieler, T; Willenbacher, W; Zijlstra, JM1
Aurer, I; Basic-Kinda, S; Dotlic, S; Durakovic, N; Hude, I; Karlak, I; Livaja Radman, I; Lubina, ZI; Peric, Z1
Engel, C; Loeffler, M; Loibl, S; Schirm, S; Scholz, M1
Avigdor, A; Battistini, R; Bergesio, F; Biggi, A; Billio, A; Bolis, S; Cantonetti, M; Chauvie, S; Chiaravalloti, A; Cimminiello, M; Corradini, P; Fallanca, F; Ferreri, AJM; Ficola, U; Gallamini, A; Gavarotti, P; Gianni, AM; Gini, G; Gottardi, D; Gregianin, M; La Nasa, G; Miglino, M; Mulé, A; Parvis, G; Patti, C; Pavoni, C; Picardi, M; Prosperini, G; Rambaldi, A; Rapezzi, D; Romano, A; Rossi, A; Schiavotto, C; Tarella, C; Trentin, L; Viero, P; Viviani, S; Zanotti, R1
Hiroshima, Y; Joshita, S; Kawata, K; Kimura, T; Kobayashi, H; Mori, H; Tanaka, E; Tanaka, N; Umemura, T; Wada, S; Wakabayashi, SI1
Cerchione, C; Chiarenza, A; Di Raimondo, F; Ippolito, M; Palumbo, GA; Parrinello, NL; Romano, A; Vetro, C1
Bröckelmann, PJ; Engert, A; Sasse, S1
Ben Lakhal, R; BenAhmed, S; BenOthmen, T; BenSalah, H; BenYoussef, Y; Bouaouina, N; Daoued, J; Elloumi, M; Ezzaier, F; Frikha, H; Frikha, M; Hdiji, S; Khelif, A; Laatiri, MA; Ladeb, S; Maalej, M; Meddeb, B; Messai, T; Mezlini, A; Mokrani, A; Msaddek, F; Tebra, S; Toumi, N; Zriba, S1
Albano, D; Galia, M; Midiri, M; Patti, C1
Baues, C; Behringer, K; Böll, B; Borchmann, P; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Greil, R; Markova, J; Meissner, J; Neubauer, A; Plütschow, A; Sasse, S; Topp, MS; von Tresckow, B; Zijlstra, JM1
Bartlett, NL; Chang, JE; Cheson, BD; Friedberg, JW; Grecula, JC; Hsi, ED; Jung, SH; Kahl, BS; Kostakoglu, L; Leonard, JP; Moskowitz, CH; Pitcher, B; Popplewell, LL; Schöder, H; Straus, DJ; Wagner-Johnston, N1
Baues, C; Borchmann, P; Dietlein, M; Drzezga, A; Engert, A; Goergen, H; Hoekstra, O; Kobe, C; Kuhnert, G; Mettler, J; Voltin, CA; Zijlstra, J1
Gültürk, E; Karaali, CN; Turan Erkek, E; Yılmaz, G1
Długosz-Danecka, M; Giza, A; Jurczak, W; Kocurek, A; Koźlik, P; Kużdżał, J; Małkowski, B; Sowa-Staszczak, A; Szmit, S; Zimowska-Curyło, D1
Cho, KK; Lyes, SM; Shetty, A1
Abbassi, LM; Arsène-Henry, A; Dendale, R; Goudjil, F; Kirova, YM1
Barr, PM; Bartlett, NL; Evens, AM; Friedberg, JW; Hsi, ED; Kahl, BS; Knopp, MV; LaCasce, AS; LeBlanc, M; Leonard, JP; Li, H; Moskowitz, CH; Rimsza, LM; Schöder, H; Smith, SM; Stephens, DM; Straus, DJ1
Asad, M; Mehreen, A; Ria, S; Sindhu, II; Wali, RM1
Anderson, NR; Collins, J; O'Bryen, J1
Farrugia, MK; Vargo, JA1
Chan, K; Cheung, MC; Prica, A; Vijenthira, A1
Brown, AM; Devata, S; Marini, BL; Nachar, VR; Perissinotti, AJ; Reid, JH1
Adouni, O; Bertucci, F; Birnbaum, D; Finetti, P; Gamoudi, A; Manai, M; Mezlini, A; Zawati, I1
Angelov, D; Cotter, AG; Fay, M; Lambert, JS; McGettrick, P; McGinty, T; O'Kelly, B; Sheehan, G1
Bohn, JP; Botto, B; Cavallo, F; Cerchione, C; Cuzzocrea, S; De Lorenzo, S; Dogliotti, I; Ferrero, S; Loseto, G; Martinelli, G; Mian, M; Mondello, P; Musolino, C; Nappi, D; Schmitt, C; Straus, DJ; Willenbacher, W; Wolf, D1
Charakopoulos, E; Diamantopoulos, PT; Giannakopoulou, N; Hatzidavid, S; Spyrou, I; Viniou, NA1
André, MPE; Bellei, M; Brice, P; Brière, J; Carde, P; Casasnovas, O; Clément-Filliatre, L; Depaus, J; Douxfils, J; Dupuis, J; Federico, M; Fortpied, C; Gianni, AM; Gobbi, PG; Heczko, M; Hutchings, M; Iannitto, E; Mounier, N; Rambaldi, A; Valagussa, P; Viviani, S; Zinzani, PL1
Ahmed, K; Amin, MSA; Brunckhorst, O; Gleeson, M; Kazmi, M; Scott, C; Wrench, D1
Baues, C; Behringer, K; Borchmann, P; Bröckelmann, PJ; Engert, A; Fuchs, M; Guhl, T; Moccia, AA; Müller, H; Pabst, T; Rank, A; Soekler, M; Vieler, T; von Tresckow, B1
Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F1
Collins, A; Cooke, L; Docherty, S; Follows, GA; Fowler, A; Grigoropoulos, N; Hodson, A; Johnson, P; Karanth, M; Kirkwood, AA; Lentell, I; Maw, K; Padayatty, J; Qian, W; Russell, J; Sadullah, S; Saha, C; Shah, N; Uttenthal, BJ1
Baues, C; Borchmann, P; Bühnen, I; Eichenauer, DA; Engert, A; Fuchs, M; Goergen, H; Hartmann, S; Kobe, C; Kreissl, S; van Heek, L; von Tresckow, B1
Ashykhmin, A; Gorbach, O; Kadnikova, T; Karnabeda, O; Karpova, O; Kmetyuk, I; Kosinova, V; Kostiukova, N; Kozlov, V; Kriachok, I; Lukjanec, O; Mykhalska, L; Novikov, M; Novosad, O; Oliinichenko, O; Pastushenko, I; Skrypets, T; Stratienko, V1
Altenbuchinger, M; Borchmann, P; Chan, FC; Engert, A; Glehr, G; Hansmann, ML; Haverkamp, H; Jachimowicz, RD; Klapper, W; Möller, P; Müller, H; Rehberg, T; Reinhardt, HC; Rosenwald, A; Scott, DW; Spang, R; Steidl, C; Stein, H; Thorns, C; von Tresckow, B1
Cui, F; Yan, J; Zhao, S1
Ando, J; Ando, M; Komatsu, N; Yasuda, H1
Hou, SL; Li, L; Lian, K; Zhang, QH1
Ferguson, G; Haynes, E; Hopkins, D; Leach, M; McKay, P; Murray, J; Osborne, W; Parsons, K; Quinn, D; Robertson, E; Wilson, MR1

Reviews

56 review(s) available for etoposide and procarbazine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Hypersensitivity reactions.
    Seminars in oncology, 1992, Volume: 19, Issue:5

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Aziridines; Benzoquinones; Bleomycin; Chlorambucil; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Drug Hypersensitivity; Etoposide; Fluorouracil; Humans; Ifosfamide; Melphalan; Methotrexate; Mitomycins; Neoplasms; Paclitaxel; Pentostatin; Procarbazine; Teniposide

1992
[Follicular lymphomas. Therapeutic indications].
    Presse medicale (Paris, France : 1983), 1992, Apr-11, Volume: 21, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Interferon-alpha; Leucovorin; Lymphoma, Follicular; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine

1992
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine

1991
[Treatment of relapses and failures in disseminated Hodgkin's disease].
    Presse medicale (Paris, France : 1983), 1991, Nov-02, Volume: 20, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine

1991
[Non-Hodgkin's lymphomas: recent achievements and therapeutic perspectives].
    Revue medicale de Bruxelles, 1985, Volume: 6, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Vincristine

1985
Current chemotherapy of small cell lung cancer.
    Chest, 1986, Volume: 89, Issue:4 Suppl

    Topics: Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Complement Membrane Attack Complex; Complement System Proteins; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Mitomycin; Mitomycins; Podophyllotoxin; Procarbazine; Prognosis; Time Factors; Vincristine

1986
The hematologic malignancies. Leukemia, lymphoma, and myeloma.
    Cancer, 1984, Dec-01, Volume: 54, Issue:11 Suppl

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Interferons; Leukemia; Lymphoma; Mechlorethamine; Multiple Myeloma; Prednisone; Procarbazine; Prognosis; Translocation, Genetic; Vincristine

1984
Oral therapy for small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 12 Suppl 3

    Topics: Administration, Oral; Altretamine; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cyclophosphamide; Etoposide; Humans; Ifosfamide; Infusions, Intravenous; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine

1995
Dose-escalation study for the treatment of Hodgkin's disease. The German Hodgkin Study Group (GHSG).
    Annals of hematology, 1993, Volume: 66, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vincristine

1993
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
    Blood, 1996, May-15, Volume: 87, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine

1996
Chemotherapy of intermediate-grade non-Hodgkin's lymphoma: is "more" or "less" better?
    Oncology (Williston Park, N.Y.), 1995, Volume: 9, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine

1995
[Chemotherapy of relapsed AML and ALL].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Etoposide; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Mechlorethamine; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Recurrence; Remission Induction; Vinblastine

1996
Burkitt's lymphoma-leukemia in patients treated for Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Follicular; Mechlorethamine; Mediastinal Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Spinal Neoplasms; Thoracic Vertebrae; Vinblastine; Vincristine

1996
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine

1998
[Chemotherapy for non-Hodgkin's lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine

1998
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
Model based development of the BEACOPP regimen for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Division; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Forecasting; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Kinetics; Models, Theoretical; Prednisone; Procarbazine; Research Design; Treatment Outcome; Vincristine

1998
Pediatric Hodgkin's disease: treatment in the late 1990s.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infant, Newborn; Male; Prednisone; Procarbazine; Treatment Outcome; Vincristine

1998
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Hodgkin Disease; Humans; Infertility; Mechlorethamine; Prednisolone; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Safety; Treatment Outcome; Vinblastine; Vincristine

2000
New treatments for Hodgkin's disease.
    Current treatment options in oncology, 2002, Volume: 3, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Radiotherapy; Vincristine

2002
[Erythema nodosum association with malignant lymphoma].
    Medicina (Kaunas, Lithuania), 2003, Volume: 39, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Erythema Induratum; Erythema Nodosum; Etoposide; Female; Hodgkin Disease; Humans; Lymphoma, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Paraneoplastic Syndromes; Prednisolone; Prednisone; Pregnancy; Procarbazine; Remission Induction; Vincristine

2003
What is the treatment of choice for advanced-stage Hodgkin's lymphoma: ABVD, Stanford V, or BEACOPP?
    Current hematology reports, 2004, Volume: 3, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Forecasting; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Multicenter Studies as Topic; Pilot Projects; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2004
Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.
    Neurology, 2004, Feb-10, Volume: 62, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Neoplasms; Cranial Irradiation; Cytarabine; Dementia; Dementia, Vascular; Demyelinating Diseases; Disease Progression; Doxorubicin; Epilepsy, Complex Partial; Etoposide; Eye Neoplasms; Fatal Outcome; Female; Gait Disorders, Neurologic; Humans; Immunocompetence; Intracranial Arteriosclerosis; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Procarbazine; Radiation Injuries; Retrospective Studies; Survival Analysis; Thiotepa; Vincristine

2004
[Treating Hodgkin's disease: for whom the more means better?].
    Magyar onkologia, 2004, Volume: 48, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Treatment Outcome; Vincristine

2004
[Primary treatment of advanced Hodgkin's disease].
    Orvosi hetilap, 2005, Jan-30, Volume: 146, Issue:5

    Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Meta-Analysis as Topic; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Risk Factors; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine

2005
ABVD, the Stanford V regimen, and BEACOPP for Hodgkin's lymphoma: what should an oncologist do?
    Clinical lymphoma, 2005, Volume: 6, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine

2005
Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Journal of the National Cancer Institute, 2006, Apr-19, Volume: 98, Issue:8

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Europe; Hematologic Neoplasms; Humans; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Mantle-Cell; Lymphoma, Non-Hodgkin; Meta-Analysis as Topic; Multicenter Studies as Topic; Multiple Myeloma; National Institutes of Health (U.S.); Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Procarbazine; Pyrazines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Transplantation, Autologous; United States; Vinblastine; Vincristine

2006
Could BEACOPP be the new standard for the treatment of advanced Hodgkin's lymphoma (HL)?
    Cancer investigation, 2006, Volume: 24, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vincristine

2006
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2007, Volume: 37, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Heart Diseases; Hodgkin Disease; Humans; Infertility; Lung Diseases; Mechlorethamine; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Risk; Survival Rate; Vinblastine; Vincristine

2007
Risk, cure and complications in advanced hodgkin disease.
    Hematology. American Society of Hematology. Education Program, 2007

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Risk; Vinblastine; Vincristine

2007
Prophylactic use of filgrastim with ABVD and BEACOPP chemotherapy regimens for Hodgkin lymphoma.
    Clinical lymphoma & myeloma, 2007, Volume: 8 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Prednisone; Procarbazine; Recombinant Proteins; Vinblastine; Vincristine

2007
Treatment of Hodgkin lymphoma: the past, present, and future.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine

2008
Standard therapy of advanced Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2009
Is BEACOPP better than ABVD?
    Current hematologic malignancy reports, 2007, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Forecasting; Hodgkin Disease; Humans; Infertility; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Patient Selection; Prednisone; Procarbazine; Remission Induction; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

2007
Chemotherapy only for localized Hodgkin lymphoma.
    Journal of internal medicine, 2011, Volume: 270, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachial Plexus; Chemotherapy, Adjuvant; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fibrosis; Gemcitabine; Heart; Hodgkin Disease; Humans; Hypothyroidism; Lung; Lymphedema; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Risk Assessment; Secondary Prevention; Survival Analysis; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2011
Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.
    The Cochrane database of systematic reviews, 2011, Aug-10, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult

2011
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
    Blood reviews, 2012, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine

2012
Fourteenth biannual report of the Cochrane Haematological Malignancies Group--focus on autologous stem cell transplantation in hematological malignancies.
    Journal of the National Cancer Institute, 2012, Jul-18, Volume: 104, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colony-Stimulating Factors; Cyclophosphamide; Dacarbazine; Disseminated Intravascular Coagulation; Doxorubicin; Etoposide; Evidence-Based Medicine; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Randomized Controlled Trials as Topic; Receptors, Thrombopoietin; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Viral Vaccines

2012
Limited-stage Hodgkin lymphoma: optimal chemotherapy and the role of radiotherapy.
    American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting, 2013

    Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Radiation-Induced; Neoplasm Staging; Neoplasms, Second Primary; Patient Selection; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2013
Refractory Hodgkin lymphoma.
    Current opinion in oncology, 2013, Volume: 25, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunologic Factors; Prednisone; Procarbazine; Stem Cell Transplantation; Transplantation, Autologous; Vincristine

2013
Effect of initial treatment strategy on survival of patients with advanced-stage Hodgkin's lymphoma: a systematic review and network meta-analysis.
    The Lancet. Oncology, 2013, Volume: 14, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
Early intensification treatment approach in advanced-stage Hodgkin lymphoma.
    Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2014
Induction therapy for advanced-stage Hodgkin lymphoma: late intensification (ABVD chemotherapy followed by high-dose chemotherapy and autologous stem cell transplant only for those who relapse).
    Hematology/oncology clinics of North America, 2014, Volume: 28, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine

2014
[Treatment strategy of Hodgkin lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Mechlorethamine; Melphalan; Molecular Targeted Therapy; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Rituximab; Vinblastine; Vincristine

2014
Current developments in the treatment of early-stage classical Hodgkin lymphoma.
    Current opinion in oncology, 2016, Volume: 28, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2016
Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
    International journal of hematology, 2016, Volume: 104, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2016
Response-adapted frontline therapy for Hodgkin lymphoma: are we there yet?
    Hematology. American Society of Hematology. Education Program, 2016, Dec-02, Volume: 2016, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glucose-6-Phosphate; Hodgkin Disease; Humans; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2016
FDG-PET for Early Response Assessment in Lymphomas: Part 1-Hodgkin Lymphoma.
    Oncology (Williston Park, N.Y.), 2017, 01-15, Volume: 31, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2017
[Primary osseous Hodgkin's lymphoma of the sacrum: A diagnostic and therapeutic challenge].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2017, Volume: 21, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; False Negative Reactions; Female; Hodgkin Disease; Humans; Infertility, Female; Low Back Pain; Magnetic Resonance Imaging; Organ Sparing Treatments; Osteomyelitis; Ovary; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Conformal; Remission Induction; Sacrum; Spinal Neoplasms; Vinblastine; Vincristine; Young Adult

2017
Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.
    The Cochrane database of systematic reviews, 2017, 05-25, Volume: 5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Young Adult

2017
Balancing risk and benefit in early-stage classical Hodgkin lymphoma.
    Blood, 2018, 04-12, Volume: 131, Issue:15

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Risk Assessment; Sex Factors; Survival Rate; Vinblastine; Vincristine

2018
Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma.
    Critical reviews in oncology/hematology, 2020, Volume: 148

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2020
Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
    Cancer medicine, 2020, Volume: 9, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Progression-Free Survival; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stem Cell Transplantation; Time Factors; Transplantation, Autologous; Vinblastine; Vincristine; Young Adult

2020
ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2021, Volume: 23, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Hodgkin Disease; Humans; Infertility, Male; Male; Prednisone; Procarbazine; Vinblastine; Vincristine

2021
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
    Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immune Checkpoint Inhibitors; Mechlorethamine; Nivolumab; Prednisolone; Procarbazine; Renal Dialysis; Vinblastine; Vincristine; Vinorelbine

2022

Trials

147 trial(s) available for etoposide and procarbazine

ArticleYear
Thymosin fraction V and intensive combination chemotherapy. Prolonging the survival of patients with small-cell lung cancer.
    JAMA, 1979, Apr-27, Volume: 241, Issue:17

    Topics: Antineoplastic Agents; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Thymosin; Thymus Hormones; Vincristine

1979
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
    Cancer treatment reports, 1979, Volume: 63, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission, Spontaneous; Vincristine

1979
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
    Medizinische Klinik (Munich, Germany : 1983), 1992, Nov-15, Volume: 87, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine

1992
Treatment of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicenter study. Kiel Lymphoma Study Group.
    Annals of internal medicine, 1992, Sep-01, Volume: 117, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Vincristine

1992
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
    Acta clinica Belgica, 1992, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mitoguazone; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vinblastine; Vincristine

1992
Treatment of children with Hodgkin's disease--results of the German Pediatric Oncology Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Germany, West; Hodgkin Disease; Humans; Male; Methotrexate; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy Dosage; Sex Factors; Survival Rate; Vincristine

1992
LOPP alternating with EVAP is superior to LOPP alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:8

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1992
Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine

1991
Long-term follow-up of ProMACE-CytaBOM in non-Hodgkin's lymphomas.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Evaluation; Etoposide; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Survival Rate; Vincristine

1991
Prospective multicenter trial for the response-adapted treatment of high-grade malignant non-Hodgkin's lymphomas: updated results of the COP-BLAM/IMVP-16 protocol with randomized adjuvant radiotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Remission Induction; Survival Rate; Vincristine

1991
ProMACE-MOPP vs MACOP-B in high grade non-Hodgkin's lymphomas: a randomised study in a multicenter cooperative study group (NHLCSG).
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vincristine

1991
ProMACE-C-MOPP in aggressive non-Hodgkin's lymphoma. Long-term results in 45 patients treated in a single institution.
    Acta oncologica (Stockholm, Sweden), 1991, Volume: 30, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1991
Intensive chemoradiotherapy and autologous bone marrow transplantation for poor prognosis neuroblastoma.
    Progress in clinical and biological research, 1991, Volume: 366

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Combined Modality Therapy; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Infant; Methotrexate; Neuroblastoma; Procarbazine; Prognosis; Transplantation, Autologous; Vincristine; Whole-Body Irradiation

1991
[Progress and obstacles in chemotherapy and combined modality treatment of small cell lung cancer].
    Nihon Kyobu Shikkan Gakkai zasshi, 1990, Volume: 28, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Vincristine

1990
Induction chemo-radiotherapy and maintenance alternating chemotherapy for small cell lung cancer.
    Acta oncologica (Stockholm, Sweden), 1990, Volume: 29, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine

1990
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
    Annals of internal medicine, 1986, Volume: 104, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednimustine; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Recurrence; Vinblastine; Vincristine

1986
[Intermediate results of the German Hodgkin's disease therapy study].
    Onkologie, 1986, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine

1986
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
    Onkologie, 1987, Volume: 10, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine

1987
German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
    Blut, 1988, Volume: 56, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1988
[Multicenter prospective risk-adapted study on the therapy of non-Hodgkin's lymphomas of high malignancy. Use of COP-BLAM/IMVP-16 and randomized adjuvant radiotherapy--study concept and preliminary results].
    Onkologie, 1988, Volume: 11, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Prednisone; Procarbazine; Vincristine

1988
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment.
    Seminars in hematology, 1988, Volume: 25, Issue:2 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Evaluation Studies as Topic; Humans; Leucovorin; Leukemia; Leukemia, Radiation-Induced; Lymph Nodes; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Neoplasms, Multiple Primary; Neoplasms, Radiation-Induced; Palliative Care; Prednisone; Procarbazine; Random Allocation; Vincristine

1988
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study].
    Onkologie, 1989, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Mesna; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Vincristine

1989
[Small cell lung cancer: a retrospective analysis of results of chemotherapy and combined modality treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:4 Pt 2-2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Nimustine; Procarbazine; Random Allocation; Remission Induction; Retrospective Studies; Vincristine

1989
[Randomized comparative study of CE (CDDP plus etoposide) and CE-AVN (ACNU, VCR plus procarbazine) as combined anticancer chemotherapy in small cell cancer of the lung].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1988, Volume: 15, Issue:4 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Administration Schedule; Etoposide; Humans; Lung Neoplasms; Nimustine; Nitrosourea Compounds; Procarbazine; Prognosis; Random Allocation; Vincristine

1988
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized study.
    American journal of clinical oncology, 1988, Volume: 11, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Prognosis; Random Allocation

1988
A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:1

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Random Allocation; Vinblastine; Vindesine

1986
Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations.
    Cancer treatment reports, 1982, Volume: 66, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leukopenia; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine

1982
Parenteral intravenous nutrition (PIVN) as an adjunct to chemotherapy in small cell anaplastic lung carcinoma.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition; Procarbazine; Random Allocation; Vincristine

1981
Early crossover of induction chemotherapy in small cell lung carcinoma.
    Australian and New Zealand journal of medicine, 1983, Volume: 13, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Procarbazine; Prospective Studies; Vincristine

1983
A prospective randomized study of adjuvant parenteral nutrition in the treatment of diffuse lymphoma: effect on drug tolerance.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Etoposide; Humans; Leucovorin; Leukocyte Count; Lymphoma; Mechlorethamine; Methotrexate; Nutrition Disorders; Parenteral Nutrition; Platelet Count; Prednisone; Procarbazine; Prospective Studies; Random Allocation; Serum Albumin; Vincristine

1981
Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Cancer treatment reports, 1981, Volume: 65 Suppl 5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bone Marrow; Carcinoma, Bronchogenic; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Gastrointestinal Diseases; Humans; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neutropenia; Parenteral Nutrition; Procarbazine; Vincristine

1981
ChlVPP/PABlOE and radiotherapy in advanced Hodgkin's disease. The Central Lymphoma Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1994
Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adult; Aged; Agranulocytosis; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Biomarkers, Tumor; Bleomycin; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Neoplasm Staging; Oncogenes; Polymerase Chain Reaction; Prednisone; Procarbazine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Proteins; Remission Induction; Treatment Outcome; Vincristine

1994
EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Life Tables; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Teniposide; Thrombocytopenia; Treatment Outcome; Vincristine

1994
MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

1994
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine

1994
Diffuse small noncleaved-cell, non-Burkitt's lymphoma in adults: a high-grade lymphoma responsive to ProMACE-based combination chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vincristine

1994
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine

1994
Peripheral T-cell non-Hodgkin's lymphomas of low malignancy: prospective study of 25 patients with pleomorphic small cell lymphoma, lymphoepitheloid cell (Lennert's) lymphoma and T-zone lymphoma. The Kiel Lymphoma Study Group.
    British journal of haematology, 1994, Volume: 87, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell, Peripheral; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Vincristine

1994
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
    Leukemia & lymphoma, 1994, Volume: 15, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine

1994
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Blood, 1995, Jul-15, Volume: 86, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1995
Efficacy of four different regimens in 64 mantle-cell lymphoma cases: clinicopathologic comparison with 498 other non-Hodgkin's lymphoma subtypes. European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recombinant Proteins; Remission Induction; Survival Rate; Teniposide; Vincristine

1995
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukopenia; Logistic Models; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Proportional Hazards Models; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Thrombocytopenia; United States; Vinblastine; Vincristine

1995
Prospective multimodality treatment of SCLC--experience during the past 18 years.
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Pneumonectomy; Postoperative Care; Prednisone; Procarbazine; Radiotherapy Dosage; Vincristine

1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisolone; Procarbazine; Remission Induction; Survival Rate; Vinblastine; Vincristine

1995
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorubicin; Etoposide; Female; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Libido; Luteinizing Hormone; Male; Mechlorethamine; Menstrual Cycle; Middle Aged; Prednisolone; Primary Ovarian Insufficiency; Procarbazine; Prospective Studies; Semen; Sex Hormone-Binding Globulin; Sperm Count; Testis; Testosterone; Vinblastine; Vincristine

1995
A randomized clinical trial in bronchogenic small-cell carcinoma evaluating alternating maintenance therapy of vincristine, adriamycin, procarbazine, and etoposide (VAPE) with cyclophosphamide, CCNU, and methotrexate (CCM) versus CCM maintenance alone in
    American journal of clinical oncology, 1994, Volume: 17, Issue:6

    Topics: Aged; Altretamine; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Procarbazine; Remission Induction; Vinblastine; Vincristine

1994
Hybrid LOPP/EVA is not better than LOPP alternating with EVAP: a prematurely terminated British National Lymphoma Investigation randomized trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Modality Therapy; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisolone; Prednisone; Procarbazine; Remission Induction; Treatment Failure; Vinblastine; Vincristine

1994
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
    Cancer, 1993, Mar-01, Volume: 71, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisolone; Prednisone; Procarbazine; Vinblastine; Vincristine

1993
Intermediate and high-grade gastric non-Hodgkin's lymphoma: a prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy.
    Leukemia & lymphoma, 1995, Volume: 17, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Gastrointestinal Hemorrhage; Humans; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine

1995
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine

1995
Clinical analysis of 670 cases in two trials of the European Organization for the Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: a comparison with the W
    Blood, 1996, May-15, Volume: 87, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Immunologic Factors; Immunophenotyping; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Prognosis; Recombinant Proteins; Survival Analysis; Survival Rate; Vincristine

1996
[Alternating chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (CHOP); etoposide, procarbazine, vindesine and prednisolone (EPVP) as a treatment for advanced-stage Hodgkin's disease].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Prednisolone; Procarbazine; Remission Induction; Vincristine; Vindesine

1996
PROMACE-MOPP and intrathecal chemotherapy for CNS lymphomas.
    Journal of neuro-oncology, 1996, Volume: 28, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Neurologic Examination; Prednisone; Procarbazine; Steroids; Survival Analysis; Vincristine

1996
Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.
    Blood, 1997, Apr-01, Volume: 89, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

1997
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1997
Hodgkin disease in children: results of a prospective randomized trial in a single institution in Argentina.
    Medical and pediatric oncology, 1997, Volume: 29, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

1997
A therapeutic trial of radiation therapy with Vincristine, etoposide, and Procarbazine (VVP) in high grade intracranial gliomas--an Eastern Cooperative Oncology Group Study (E2392).
    Journal of neuro-oncology, 1998, Volume: 37, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Middle Aged; Procarbazine; Prognosis; Survival Analysis; Vincristine

1998
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy, Adjuvant; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Incidence; Leukocyte Count; Leukopenia; Male; Mechlorethamine; Middle Aged; Platelet Count; Prednisone; Procarbazine; Prospective Studies; Recombinant Proteins; Treatment Outcome; Vinblastine; Vincristine

1998
Effect of etoposide on the pharmacokinetics of methotrexate in vivo.
    Anti-cancer drugs, 1998, Volume: 9, Issue:9

    Topics: Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Cisplatin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Etoposide; Humans; Leucovorin; Medulloblastoma; Methotrexate; Mitolactol; Procarbazine

1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study Group.
    Blood, 1998, Dec-15, Volume: 92, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Survival Rate; Treatment Outcome; Vincristine

1998
BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Czech Republic; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Switzerland; Treatment Outcome; Vinblastine; Vincristine

1998
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine

1998
Pediatric Hodgkin's disease: treatment in the late 1990s.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9 Suppl 5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Infant, Newborn; Male; Prednisone; Procarbazine; Treatment Outcome; Vincristine

1998
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
    Leukemia & lymphoma, 1999, Volume: 34, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Male; Mechlorethamine; Middle Aged; Mitoguazone; Outcome Assessment, Health Care; Prednisolone; Prednisone; Procarbazine; Prognosis; Prospective Studies; Vinblastine; Vincristine

1999
Chemotherapy for unresectable and recurrent intramedullary glial tumours in children. Brain Tumours Subcommittee of the French Society of Paediatric Oncology (SFOP).
    British journal of cancer, 1999, Volume: 81, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Etoposide; Follow-Up Studies; Glioma; Humans; Infant; Neoplasm Recurrence, Local; Procarbazine; Spinal Cord Neoplasms; Vincristine

1999
[Combined modality therapy for malignant lymphoma of the primary central nervous system: a preliminary report of a new chemotherapeutic regimen with "PEACE"].
    No shinkei geka. Neurological surgery, 1999, Volume: 27, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome

1999
Interferon alpha consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: results of the Southwest Oncology Group randomized phase III study 8809.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Volume: 18, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Vincristine

2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
    Haematologica, 2000, Volume: 85, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2000
Acute hematologic toxicity and practicability of dose-intensified BEACOPP chemotherapy for advanced stage Hodgkin's disease. German Hodgkin's Lymphoma Study Group (GHSG).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Platelets; Blood Transfusion; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukocyte Count; Leukocytes; Leukopenia; Male; Middle Aged; Platelet Count; Prednisone; Procarbazine; Survival Analysis; Thrombocytopenia; Time Factors; Treatment Outcome; Vincristine

2000
Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Mar-01, Volume: 19, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemotherapy, Adjuvant; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Ependymoma; Etoposide; Female; Humans; Infant; Male; Neoplasm Recurrence, Local; Procarbazine; Prognosis; Treatment Outcome; Vincristine

2001
Oral combination chemotherapy in conjunction with filgrastim (G-CSF) in the treatment of AIDS-related non-Hodgkin's lymphoma: evaluation of the role of G-CSF; quality-of-life analysis and long-term follow-up.
    American journal of hematology, 2001, Volume: 66, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Etoposide; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Outcome Assessment, Health Care; Procarbazine; Prognosis; Quality of Life; Recombinant Proteins; Survival Rate; Treatment Outcome

2001
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
    British journal of cancer, 2001, May-18, Volume: 84, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine

2001
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jan-15, Volume: 20, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2002
Feasibility of upfront dose-intensive chemotherapy in children with advanced-stage Hodgkin's lymphoma: preliminary results from the Children's Cancer Group Study CCG-59704.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2002
Current clinical trials for the treatment of advanced-stage Hodgkin's disease: BEACOPP.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Meta-Analysis as Topic; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Treatment Outcome; Vincristine

2002
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2002, Jul-01, Volume: 20, Issue:13

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Italy; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Procarbazine; Prognosis; Treatment Outcome; United Kingdom; Vinblastine; Vincristine

2002
Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.
    Blood, 2002, Dec-15, Volume: 100, Issue:13

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hematologic Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine

2002
14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, May-01, Volume: 21, Issue:9

    Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Leukopenia; Male; Middle Aged; Prednisone; Procarbazine; Survival; Thrombocytopenia; Treatment Outcome; Vincristine

2003
Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Leukemia; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Vinblastine; Vincristine

2003
Treatment of intermediate and advanced stage Hodgkin's disease with modified baseline BEACOPP regimen: a Hellenic Co-operative Oncology Group Study.
    European journal of haematology, 2003, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Time Factors; Vincristine

2003
BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:10

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Immunocompromised Host; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; RNA; Treatment Outcome; Vincristine

2003
Treatment of advanced Hodgkin's disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin's Lymphoma Study Group HD6 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Prognosis; Sex Factors; Treatment Outcome; Vinblastine; Vincristine

2004
Severe pulmonary toxicity in patients with advanced-stage Hodgkin's disease treated with a modified bleomycin, doxorubicin, cyclophosphamide, vincristine, procarbazine, prednisone, and gemcitabine (BEACOPP) regimen is probably related to the combination o
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2004, Jun-15, Volume: 22, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Gemcitabine; Hodgkin Disease; Humans; Lung Diseases; Male; Middle Aged; Prednisone; Procarbazine; Vincristine

2004
A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Volume: 16, Issue:1

    Topics: Administration, Oral; Aged; Aging; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infusions, Intravenous; Prednisone; Procarbazine; Prospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2005
A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.
    International journal of radiation oncology, biology, physics, 2005, Sep-01, Volume: 63, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Genes, bcl-2; Humans; Lymphoma, Follicular; Methylprednisolone; Middle Aged; Mitoxantrone; Polymerase Chain Reaction; Prednisone; Procarbazine; Prospective Studies; Translocation, Genetic; Vincristine

2005
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2005
Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Drug Resistance, Multiple; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisolone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2005
A phase II study of VEPA/FEPP chemotherapy for aggressive lymphoma in elderly patients: Japan Clinical Oncology Group Study JCOG9203.
    International journal of hematology, 2006, Volume: 83, Issue:1

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisolone; Procarbazine; Treatment Outcome; Vincristine; Vindesine

2006
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
    Haematologica, 2006, Volume: 91, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Polyethylene Glycols; Prednisone; Procarbazine; Recombinant Proteins; Risk; Treatment Outcome; Vincristine

2006
Oral combination chemotherapy in the treatment of AIDS-associated Hodgkin's disease.
    East African medical journal, 2005, Volume: 82, Issue:9 Suppl

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Lymphoma, AIDS-Related; Male; Middle Aged; Procarbazine; Survival Analysis

2005
Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome.
    Blood, 2007, Feb-01, Volume: 109, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2007
Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma.
    Leukemia & lymphoma, 2006, Volume: 47, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2006
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicity.
    Clinical pharmacokinetics, 2007, Volume: 46, Issue:4

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Surface Area; Cyclophosphamide; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Middle Aged; Phenotype; Platelet Count; Prednisone; Procarbazine; Vincristine

2007
Salvage therapy and late neurotoxicity in patients with recurrent primary CNS lymphoma treated with a modified ProMACE-MOPP hybrid regimen.
    Leukemia & lymphoma, 2007, Volume: 48, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neurotoxicity Syndromes; Prednisone; Procarbazine; Retrospective Studies; Salvage Therapy; Survival Analysis; Vincristine

2007
A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
    International journal of radiation oncology, biology, physics, 2007, Nov-15, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mediastinal Neoplasms; Middle Aged; Neoplasm, Residual; Prednisone; Procarbazine; Quality Assurance, Health Care; Radiotherapy; Tomography, X-Ray Computed; Vincristine

2007
Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud
    International journal of radiation oncology, biology, physics, 2008, Jan-01, Volume: 70, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Deoxycytidine; Doxorubicin; Drug Interactions; Etoposide; Female; Gemcitabine; Germany; Hodgkin Disease; Humans; Lung; Male; Middle Aged; Pilot Projects; Prednisone; Procarbazine; Remission Induction; Vincristine

2008
Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).
    Blood, 2008, Jan-01, Volume: 111, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fertility; Follicle Stimulating Hormone; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Sperm Count; Testosterone; Vincristine

2008
Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP-C) oral combination chemotherapy regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
    Cancer, 2008, May-15, Volume: 112, Issue:10

    Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Etoposide; Humans; Lymphoma; Lymphoma, Mantle-Cell; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Time Factors

2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma.
    Blood, 2008, Nov-15, Volume: 112, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Radiography; Radiopharmaceuticals; Risk Factors; Survival Rate; Vincristine

2008
ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Feb-10, Volume: 27, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin's lymphoma has a high negative predictive value.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2009, Volume: 20, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Treatment Outcome; Vincristine; Young Adult

2009
Bone marrow stem cell damage after three different chemotherapy regimens for advanced Hodgkin's lymphoma.
    Oncology reports, 2009, Volume: 21, Issue:4

    Topics: Adolescent; Adult; Aged; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
Two cycles of escalated BEACOPP followed by four cycles of ABVD utilizing early-interim PET/CT scan is an effective regimen for advanced high-risk Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010
Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Sep-20, Volume: 27, Issue:27

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2009
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pericarditis; Peripheral Blood Stem Cell Transplantation; Pneumonia; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2009
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide regimen in elderly patients with recurrent mantle cell lymphoma.
    Cancer, 2010, Jun-01, Volume: 116, Issue:11

    Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma, Mantle-Cell; Male; Middle Aged; Neovascularization, Pathologic; Prednisone; Procarbazine; Quality of Life; Recurrence; Rituximab; Thalidomide; Treatment Outcome

2010
No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Volume: 21, Issue:10

    Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Contraceptives, Oral; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fertility; Germany; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Neoplasm Staging; Ovarian Follicle; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vincristine; Young Adult

2010
Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, May-01, Volume: 28, Issue:13

    Topics: Adolescent; Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Double-Blind Method; Doxorubicin; Epoetin Alfa; Erythrocyte Transfusion; Erythropoietin; Etoposide; Fatigue; Female; Germany; Hematinics; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Prospective Studies; Recombinant Proteins; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Vincristine; Young Adult

2010
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Sep-20, Volume: 28, Issue:27

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Procarbazine; Radiation Dosage; Radiotherapy, Adjuvant; Time Factors; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2010
BEACOPP chemotherapy is a highly effective regimen in children and adolescents with high-risk Hodgkin lymphoma: a report from the Children's Oncology Group.
    Blood, 2011, Mar-03, Volume: 117, Issue:9

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Time Factors; Treatment Outcome; Vincristine; Young Adult

2011
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.
    British journal of haematology, 2011, Volume: 152, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Substitution; Epidemiologic Methods; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine

2011
Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.
    Pediatric blood & cancer, 2011, Jul-15, Volume: 57, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Infant, Newborn; Lomustine; Male; Procarbazine; Retrospective Studies; Survival Rate; Thioguanine; Vinblastine; Vincristine

2011
Ranimustine, ifosfamide, procarbazine, dexamethasone, and etoposide therapy for central nervous system recurrence of diffuse large B-cell lymphoma in patients with poor performance status: a pilot study.
    Leukemia & lymphoma, 2011, Volume: 52, Issue:10

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Dexamethasone; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Nitrosourea Compounds; Pilot Projects; Procarbazine; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome

2011
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned.
    The New England journal of medicine, 2011, Jul-21, Volume: 365, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Proportional Hazards Models; Remission Induction; Salvage Therapy; Vinblastine; Vincristine; Young Adult

2011
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:3

    Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2012
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial o
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Treatment Failure; Vincristine

2011
Dose-intensification in early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD14 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Mar-20, Volume: 30, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
    Lancet (London, England), 2012, May-12, Volume: 379, Issue:9828

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Proportional Hazards Models; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine

2012
Treatment of newly diagnosed advanced stage Hodgkin lymphoma.
    Blood reviews, 2012, Volume: 26, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Retrospective Studies; Vinblastine; Vincristine

2012
Treatment of advanced stage Hodgkin lymphoma--it's all about risk-benefit.
    British journal of haematology, 2012, Volume: 159, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Risk Assessment; Vinblastine; Vincristine

2012
Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Nov-20, Volume: 30, Issue:33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; HIV Infections; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2012
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Aug-01, Volume: 31, Issue:22

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Mass Index; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Retrospective Studies; Risk Factors; Vinblastine; Vincristine

2013
Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Apr-20, Volume: 32, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Prospective Studies; Vinblastine; Vincristine; Young Adult

2014
Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jun-10, Volume: 32, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Vincristine; Young Adult

2014
ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥ 4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2014, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2014
Phase II study of interim PET-CT-guided response-adapted therapy in advanced Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; India; Kaplan-Meier Estimate; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2015
Relapse analysis of irradiated patients within the HD15 trial of the German Hodgkin Study Group.
    International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Germany; Hodgkin Disease; Humans; Middle Aged; Neoplasm, Residual; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Recurrence; Vincristine

2015
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jun-10, Volume: 33, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; North America; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2015
Impact of Bleomycin and Vincristine Dose Reductions in Patients With Advanced Hodgkin Lymphoma Treated With BEACOPP: An Analysis of the German Hodgkin Study Group HD12 and HD15 Trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Aug-01, Volume: 33, Issue:22

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Procarbazine; ROC Curve; Time Factors; Treatment Outcome; Vincristine

2015
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine

2016
Targeted BEACOPP Variants in Patients With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma: Final Analysis of a Randomized Phase II Study.
    Clinical advances in hematology & oncology : H&O, 2016, Volume: 14, Issue:2 Suppl 1

    Topics: Anemia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hematologic Tests; Hodgkin Disease; Humans; Prednisone; Procarbazine; Thrombocytopenia; Vincristine

2016
US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Vinblastine; Vincristine; Young Adult

2016
Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 06-10, Volume: 34, Issue:17

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Male; Medication Adherence; Middle Aged; Prednisone; Procarbazine; Risk Factors; Vinblastine; Vincristine

2016
Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jun-01, Volume: 35, Issue:16

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Young Adult

2017
Long-Term Follow-Up of Contemporary Treatment in Early-Stage Hodgkin Lymphoma: Updated Analyses of the German Hodgkin Study Group HD7, HD8, HD10, and HD11 Trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, Jun-20, Volume: 35, Issue:18

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Radiotherapy Dosage; Survival Rate; Time Factors; Vinblastine; Vincristine; Young Adult

2017
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
    British journal of haematology, 2017, Volume: 178, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy, Adjuvant; Vinblastine; Vincristine; Young Adult

2017
ABVD or BEACOPP
    European journal of cancer (Oxford, England : 1990), 2017, Volume: 81

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Risk Factors; Survival Analysis; Vinblastine; Vincristine; Young Adult

2017
PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
    Lancet (London, England), 2017, 12-23, Volume: 390, Issue:10114

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Czech Republic; Doxorubicin; Etoposide; Female; Germany; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Netherlands; Positron-Emission Tomography; Prednisone; Procarbazine; Rituximab; Switzerland; Treatment Outcome; Vincristine; Young Adult

2017
Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Tria
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 02-10, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prospective Studies; Radiotherapy; Rituximab; Survival Analysis; Vinblastine; Vincristine; Young Adult

2018
Outcome of Patients With Early-Stage Infradiaphragmatic Hodgkin Lymphoma: A Comprehensive Analysis From the German Hodgkin Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2018, 09-01, Volume: 36, Issue:25

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Middle Aged; Prednisone; Procarbazine; Progression-Free Survival; Treatment Outcome; Vincristine; Young Adult

2018
CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET.
    Blood, 2018, 09-06, Volume: 132, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine

2018
Outcome-based interpretation of early interim PET in advanced-stage Hodgkin lymphoma.
    Blood, 2018, 11-22, Volume: 132, Issue:21

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vincristine; Young Adult

2018
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma.
    Blood, 2019, 10-10, Volume: 134, Issue:15

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult

2019
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study.
    The Lancet. Haematology, 2020, Volume: 7, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Canada; Cost-Benefit Analysis; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2020
ABVD vs BEACOPP escalated in advanced-stage Hodgkin's lymphoma: Results from a multicenter European study.
    American journal of hematology, 2020, Volume: 95, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Italy; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine

2020
A Ukrainian multicenter prospective study of the value of PET/ CT prognostic role in primary patients with Hodgkins lymphoma in a real-life cohort.
    Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2020,Winter, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Prognosis; Prospective Studies; Survival Analysis; Ukraine; Vinblastine; Vincristine; Young Adult

2020

Other Studies

228 other study(ies) available for etoposide and procarbazine

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:4

    Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Non-Hodgkin's malignant lymphomata in adults: chemo-radiotherapy in stages III and IV.
    The British journal of cancer. Supplement, 1975, Volume: 2

    Topics: Adult; Antineoplastic Agents; Azirines; Bleomycin; Cyclophosphamide; Daunorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Prednisone; Procarbazine; Teniposide; Triethylenemelamine; Vinblastine; Vincristine

1975
Intensive induction therapy for small cell carcinoma of the lung.
    Cancer treatment reports, 1979, Volume: 63, Issue:4

    Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Remission, Spontaneous; Vincristine

1979
Parathyroid hormone-related protein as a cause of hypercalcemia in a B-cell type malignant lymphoma.
    Internal medicine (Tokyo, Japan), 1992, Volume: 31, Issue:8

    Topics: Aclarubicin; Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Cisplatin; Creatinine; Cyclic AMP; Cytarabine; Etoposide; Glomerular Filtration Rate; Humans; Hydroxycholecalciferols; Hydroxyproline; Hypercalcemia; Ifosfamide; L-Lactate Dehydrogenase; Lymphoma, B-Cell; Male; Osteocalcin; Parathyroid Hormone; Parathyroid Hormone-Related Protein; Prednisolone; Procarbazine; Proteins

1992
[The treatment of small cell lung cancer].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1992, Volume: 14, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemotherapy, Adjuvant; Cyclophosphamide; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Survival Rate; Vincristine

1992
[A case of diffuse large cell lymphoma treated with combination chemotherapy of CHOP (cyclophosphamide, doxorubicin, vincristine, prednisolone) and BEMP (bleomycin, etoposide, mitoxantrone, procarbazine) with complete remission].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:2

    Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Lymphoma, Large B-Cell, Diffuse; Male; Mitoxantrone; Prednisone; Procarbazine; Remission Induction; Vincristine

1992
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Diaphragm; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymphatic Diseases; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine

1992
ABEP as primary chemotherapy for Hodgkin's disease.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:10

    Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechlorethamine; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisolone; Prednisone; Procarbazine; Vincristine

1992
[Alternating chemotherapeutic treatment in patients with localized undifferentiated small-cell carcinoma of the lung].
    Revista clinica espanola, 1991, Volume: 189, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lomustine; Lung Neoplasms; Methotrexate; Procarbazine; Remission Induction; Time Factors; Vincristine

1991
Salvage therapy for diffuse large-cell lymphoma.
    Blood, 1990, Oct-01, Volume: 76, Issue:7

    Topics: Bleomycin; Cyclophosphamide; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine

1990
Angiotropic (intravascular) large cell lymphoma. A clinicopathologic study of seven cases with unique clinical presentations.
    Cancer, 1990, Oct-15, Volume: 66, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Immunohistochemistry; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1990
Pneumothorax following cytotoxic chemotherapy in malignant lymphoma.
    Chest, 1990, Volume: 98, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Humans; Lung; Lung Neoplasms; Lymphoma; Male; Methotrexate; Middle Aged; Pneumothorax; Prednisone; Procarbazine; Radiography; Vinblastine; Vincristine

1990
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine

1990
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Mechlorethamine; Methotrexate; Middle Aged; Mouth Mucosa; Prednisone; Procarbazine; Prognosis; Remission Induction; Stomatitis; Survival Rate; Vinblastine; Vincristine

1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapy.
    European journal of haematology, 1991, Volume: 46, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Liver; Lymph Nodes; Neoplasm Staging; Prednimustine; Procarbazine; Spleen; Vinblastine

1991
[Thymus hyperplasia after chemotherapy in a case of Hodgkin's disease].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1991, Volume: 155, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Prednimustine; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine

1991
[Malignant lymphomas. Preliminary report of the National Protocol of Antineoplastic Drugs].
    Revista medica de Chile, 1991, Volume: 119, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoguazone; Neoplasm Staging; Prednisone; Procarbazine; Vincristine

1991
VP-16, vincristine and procarbazine with radiation therapy for treatment of malignant brain tumors.
    Journal of neuro-oncology, 1990, Volume: 8, Issue:2

    Topics: Adult; Aged; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Etoposide; Female; Glioblastoma; Humans; Male; Middle Aged; Procarbazine; Vincristine

1990
ECAPP chemotherapy for lymphoma.
    American journal of clinical oncology, 1990, Volume: 13, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Vincristine

1990
CEPP(B): an effective and well-tolerated regimen in poor-risk, aggressive non-Hodgkin's lymphoma.
    Blood, 1990, Oct-01, Volume: 76, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Injections, Intravenous; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Procarbazine; Remission Induction

1990
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Seminars in oncology, 1986, Volume: 13, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine

1986
Hematologic malignancies: non-Hodgkin's lymphomas.
    Hospital practice (Office ed.), 1986, Sep-15, Volume: 21, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vinblastine; Vincristine

1986
The simultaneous presentation of peripheral T-cell lymphoma and hairy cell leukemia.
    Cancer, 1987, Oct-01, Volume: 60, Issue:7

    Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Head and Neck Neoplasms; Histocytochemistry; HLA-DR Antigens; Humans; Leukemia, Hairy Cell; Lymphatic Metastasis; Lymphoma; Microscopy, Electron; Middle Aged; Prednisone; Procarbazine; Scalp; T-Lymphocytes; Vincristine

1987
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine

1987
Retrospective analysis of stage I and II indolent lymphomas at the National Cancer Institute.
    International journal of radiation oncology, biology, physics, 1988, Volume: 14, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiotherapy, High-Energy; Retrospective Studies; Vincristine

1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Italy; Lomustine; Male; Mechlorethamine; Prednimustine; Prednisone; Procarbazine; Transplantation, Autologous; Vinblastine; Vincristine

1988
[Treatment with CEP (CCNU, VP-16 and prednimustine) in Hodgkin's disease resistant to CVPP and ABVD. Results in 21 patients].
    Sangre, 1988, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Drug Evaluation; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1988
Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine

1989
[Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Etoposide; Female; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Middle Aged; Prednisolone; Procarbazine

1989
Sequential combination chemotherapy (CABOPP/VIM) for the treatment of high-grade malignant non-Hodgkin lymphoma.
    Acta oncologica (Stockholm, Sweden), 1989, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vincristine

1989
VP16, epirubicin and procarbazine in the treatment of advanced non-small-cell lung cancer.
    Tumori, 1989, Apr-30, Volume: 75, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Epirubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Middle Aged; Procarbazine

1989
Third-line salvage chemotherapy in Hodgkin's disease.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Middle Aged; Prednimustine; Prednisone; Procarbazine; Vinblastine; Vincristine

1985
ProMACE-MOPP combination chemotherapy for diffuse lymphomas.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine

1985
Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Vincristine

1989
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer].
    Bulletin du cancer, 1987, Volume: 74, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Etoposide; Humans; Lung Neoplasms; Melphalan; Procarbazine

1987
Results of a combined chemo-radiotherapeutic program in 61 patients affected by small cell lung cancer.
    Tumori, 1988, Apr-30, Volume: 74, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Radiography; Vincristine; Vomiting

1988
Neurologic dysfunction in patients treated for small cell carcinoma of the lung: a clinical and radiological study.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain; Brain Diseases; Brain Neoplasms; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Mitomycin; Mitomycins; Procarbazine; Vincristine

1986
Long-term effects of intravenous hyperalimentation administered during intensive chemotherapy for small cell bronchogenic carcinoma.
    Cancer, 1987, Jan-15, Volume: 59, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Hypersensitivity, Delayed; Ifosfamide; Lung Neoplasms; Male; Methotrexate; Middle Aged; Parenteral Nutrition, Total; Procarbazine; Prognosis; Vincristine

1987
Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:5

    Topics: Adenocarcinoma; Aged; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Carcinoma, Bronchogenic; Carcinoma, Squamous Cell; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Neoplasm Metastasis; Procarbazine; Progesterone; Prognosis; Serum Albumin; Vinblastine

1986
Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.
    International journal of radiation oncology, biology, physics, 1984, Volume: 10, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Procarbazine; Radiotherapy Dosage; Vincristine

1984
Effects of intensive induction chemotherapy for extensive-disease small cell bronchogenic carcinoma in protected environment-prophylactic antibiotic units.
    The American journal of medicine, 1984, Volume: 76, Issue:3

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cyclophosphamide; Doxorubicin; Environment, Controlled; Etoposide; Female; Humans; Ifosfamide; Leukocyte Count; Lung Neoplasms; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Procarbazine; Vincristine

1984
Prolonged initial remission in patients with nodular mixed lymphoma.
    Annals of internal medicine, 1984, Volume: 100, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Follicular; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Time Factors; Vincristine

1984
Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy.
    Annals of internal medicine, 1983, Volume: 98, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood Platelets; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Etoposide; Female; Humans; Leucovorin; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Vincristine

1983
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
    American journal of hematology, 1995, Volume: 50, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Killer Cells, Natural; Lymphocytes; Lymphocytosis; Mechlorethamine; Neoplasm Staging; Prednisone; Procarbazine; T-Lymphocytes; Vinblastine; Vincristine

1995
Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
    Bone marrow transplantation, 1994, Volume: 13, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Prednisone; Procarbazine; Rectal Neoplasms; Risk Factors; Seminoma; Testicular Neoplasms; Transplantation, Autologous; Vincristine

1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Pancytopenia; Prednisone; Procarbazine; Prospective Studies; Recurrence; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine; Vincristine

1994
Visual hallucinations following treatment with vincristine.
    Clinical and laboratory haematology, 1994, Volume: 16, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine

1994
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.
    Blood, 1995, Nov-15, Volume: 86, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Cell Survival; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Glyoxal; Graft Survival; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Middle Aged; Multivariate Analysis; Prednimustine; Prednisolone; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Vinblastine; Vincristine

1995
Aggressive treatment for postcardiac transplant lymphoproliferation.
    Blood, 1995, Nov-01, Volume: 86, Issue:9

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppression Therapy; Life Tables; Lymphoproliferative Disorders; Male; Mechlorethamine; Methotrexate; Middle Aged; Multiple Organ Failure; Postoperative Complications; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

1995
Predicting neutropenia after chemotherapy for lymphoma.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:1-2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Leukocyte Count; Lymphoma; Male; Mechlorethamine; Middle Aged; Neutropenia; Predictive Value of Tests; Prednisolone; Procarbazine; Retrospective Studies; Risk Factors; Thrombocytopenia; Vinblastine; Vincristine

1993
[Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1993, Volume: 34, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Vincristine

1993
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Infant, Newborn; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Melphalan; Podophyllotoxin; Prednisone; Pregnancy; Pregnancy Outcome; Procarbazine; Remission Induction; Salvage Therapy; Vincristine

1994
Excretion of Ascaris lumbricoides during total body irradiation.
    Bone marrow transplantation, 1994, Volume: 13, Issue:4

    Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Ascariasis; Ascaris lumbricoides; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gastrointestinal Contents; Humans; Intestinal Diseases, Parasitic; Leucovorin; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Vincristine; Vomiting; Whole-Body Irradiation

1994
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
    British journal of cancer, 1994, Volume: 70, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Etoposide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Mechlorethamine; Middle Aged; Prednisolone; Procarbazine; Sex Hormone-Binding Globulin; Testosterone; Vinblastine

1994
Relapsing chickenpox in a young man with non-Hodgkin's lymphoma.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:5

    Topics: Acyclovir; Adult; Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Herpesvirus 3, Human; Humans; Immunocompromised Host; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Recurrence; Vincristine; Virus Activation

1994
CAPE/PALE salvage chemotherapy for Hodgkin's disease patients relapsing within 1 year of ChlVPP chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Prognosis; Remission Induction; Salvage Therapy; Survival Rate; Vinblastine

1993
ProMACE day 1/MOPP day 8 chemotherapy for prolymphocytic leukemia: a case report of prolonged survival.
    American journal of hematology, 1994, Volume: 46, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, B-Cell; Leukemia, Prolymphocytic; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Time Factors; Vincristine

1994
Novel oral combination chemotherapy in the treatment of intermediate-grade and high-grade AIDS-related non-Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Flow Cytometry; Humans; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Procarbazine; Proportional Hazards Models; Quality of Life; Survival Analysis; Treatment Outcome

1993
Combination chemotherapy in refractory immune thrombocytopenic purpura.
    The New England journal of medicine, 1993, Apr-29, Volume: 328, Issue:17

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Female; Humans; Male; Middle Aged; Prednisone; Procarbazine; Purpura, Thrombocytopenic, Idiopathic; Vincristine

1993
Oral low-dose etoposide therapy for refractory multiple myeloma with extramedullary involvement.
    Internal medicine (Tokyo, Japan), 1995, Volume: 34, Issue:10

    Topics: Administration, Oral; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Humans; Male; Multiple Myeloma; Prednisolone; Procarbazine; Remission Induction

1995
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Gene Rearrangement, T-Lymphocyte; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Recurrence; Time Factors; Vinblastine; Vincristine

1995
[Spinal cord compression as the presenting form of non-Hodgkin's lymphoma].
    Sangre, 1995, Volume: 40, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epidural Space; Etoposide; Female; Humans; Laminectomy; Leucovorin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Large B-Cell, Diffuse; Mechlorethamine; Methotrexate; Middle Aged; Paresis; Paresthesia; Prednisone; Procarbazine; Soft Tissue Neoplasms; Spinal Cord Compression; Spinal Neoplasms; Thoracic Neoplasms; Thoracic Vertebrae; Urinary Retention; Vincristine

1995
Successful treatment of lymphomatoid granulomatosis using cyclosporin-A after failure of intensive chemotherapy.
    American journal of hematology, 1996, Volume: 53, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; CD4-Positive T-Lymphocytes; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Doxorubicin; Etoposide; Humans; Immunosuppressive Agents; Lung Diseases; Lymphomatoid Granulomatosis; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Recurrence; Remission Induction; Salvage Therapy; Vincristine

1996
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Pilot Projects; Prednisone; Procarbazine; Treatment Outcome; Vincristine

1997
Salvage treatment after failure or relapse following initial chemotherapy for follicular non-Hodgkin's lymphoma.
    Leukemia & lymphoma, 1997, Volume: 24, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Humans; Life Tables; Lymphoma, Follicular; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Procarbazine; Prognosis; Proportional Hazards Models; Remission Induction; Salvage Therapy; Survival Analysis; Vincristine

1997
High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
    Hematological oncology, 1996, Volume: 14, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Prednisone; Procarbazine; Prospective Studies; Radiotherapy, Adjuvant; Stomach Neoplasms; Vincristine

1996
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
    British journal of cancer, 1998, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine

1998
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
    Hematological oncology, 1997, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fibrin Fibrinogen Degradation Products; Hodgkin Disease; Humans; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Mitoxantrone; Partial Thromboplastin Time; Plasminogen; Prednisone; Procarbazine; Protein C; Protein S; Thrombophilia; Time Factors; Vinblastine; Vincristine

1997
The effects of etoposide on testicular function in boys treated for Hodgkin's disease.
    Cancer, 1998, Nov-15, Volume: 83, Issue:10

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Methotrexate; Prednisone; Procarbazine; Puberty; Remission Induction; Testis; Testosterone; Vincristine

1998
ChlVPP/ABV-VP16 hybrid regimen for advanced Hodgkin's disease: a study in 36 patients.
    Leukemia & lymphoma, 1999, Volume: 33, Issue:3-4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Retrospective Studies; Survival Analysis; Time Factors; Vinblastine

1999
Hypophyseal non-Hodgkin's lymphoma presenting with diabetes insipidus: a case report.
    Journal of neuro-oncology, 1999, Volume: 42, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diabetes Insipidus; Doxorubicin; Etoposide; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Magnetic Resonance Spectroscopy; Male; Methotrexate; Middle Aged; Pituitary Neoplasms; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine

1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    British journal of cancer, 1999, Volume: 81, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Child, Preschool; Chlorambucil; Cohort Studies; Combined Modality Therapy; Cytarabine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Infant; Leukemia, Myeloid; Life Tables; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Podophyllotoxin; Prednisolone; Prednisone; Procarbazine; Retrospective Studies; Risk; Salvage Therapy; Vinblastine; Vincristine

1999
Rapid regression of chemotherapy refractory lymphocyte predominant Hodgkin's disease after administration of rituximab (anti CD 20 mono- clonal antibody) and interleukin-2.
    Leukemia & lymphoma, 1999, Volume: 35, Issue:5-6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Idarubicin; Ifosfamide; Immunization, Passive; Interleukin-2; Male; Melphalan; Middle Aged; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine

1999
Interferon does not prolong progression-free survival after ProMACE-MOPP.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2000, Sep-15, Volume: 18, Issue:18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Humans; Interferon-alpha; Lymphoma, Non-Hodgkin; Mechlorethamine; Methotrexate; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vincristine

2000
Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2000, Volume: 83, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Etoposide; Female; Humans; Prednisolone; Procarbazine; Vincristine

2000
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
    Neuro-oncology, 2000, Volume: 2, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Bone Marrow Transplantation; Brain Diseases; Brain Neoplasms; Cachexia; Cerebral Hemorrhage; Cisplatin; Disease Progression; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Survival Analysis; Survival Rate; Thiotepa; Treatment Failure; Vincristine

2000
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Practice Guidelines as Topic; Prednisone; Procarbazine; Radiotherapy; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2001
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.
    Blood, 2001, Nov-15, Volume: 98, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Diagnosis, Differential; Disease-Free Survival; Doxorubicin; Etoposide; False Negative Reactions; False Positive Reactions; Fibrosis; Fluorodeoxyglucose F18; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Life Tables; Mediastinal Neoplasms; Melphalan; Neoplasm Recurrence, Local; Predictive Value of Tests; Prednisone; Procarbazine; Prospective Studies; Radiopharmaceuticals; Radiotherapy, Adjuvant; Remission Induction; Salvage Therapy; Tomography, Emission-Computed; Transplantation, Autologous; Vinblastine; Vincristine

2001
Adult lymphoblastic lymphoma in Taiwan: an analysis of treatment results of 26 patients.
    Annals of hematology, 2001, Volume: 80, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Mechlorethamine; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Vincristine

2001
A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.
    Bone marrow transplantation, 2001, Volume: 28, Issue:9

    Topics: Adult; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Fatal Outcome; Gemcitabine; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunocompromised Host; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases, Fungal; Male; Melphalan; Neoplasm Recurrence, Local; Opportunistic Infections; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Salvage Therapy; Skin; Transplantation, Homologous; Vinblastine; Vincristine

2001
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders

2003
Hodgkin's disease--clinical trials and travails.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Mortality; Neoplasms, Second Primary; Prednisone; Procarbazine; Radiotherapy; Vincristine

2003
Chemotherapy for Hodgkin's disease.
    The New England journal of medicine, 2003, Sep-18, Volume: 349, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Administration Schedule; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vinblastine; Vincristine

2003
Graft-versus-lymphoma effect of donor lymphocyte infusion in indolent lymphomas relapsed after allogeneic stem cell transplantation.
    Bone marrow transplantation, 2003, Volume: 32, Issue:12

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Graft vs Host Disease; Graft vs Tumor Effect; Humans; Immunophenotyping; Lymphocyte Depletion; Lymphocyte Transfusion; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Prednisolone; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Tissue Donors; Transplantation, Homologous; Treatment Outcome; Vincristine

2003
VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:1

    Topics: Age Distribution; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Comorbidity; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Italy; Male; Mitoxantrone; Procarbazine; Prognosis; Prospective Studies; Vinblastine

2004
Cardiac lymphoma successfully treated with high dose chemotherapy followed by autologous haematopoietic stem cell transplantation.
    Haematologica, 2003, Volume: 88, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Chest Pain; Combined Modality Therapy; Cough; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Nitrosourea Compounds; Prednisolone; Procarbazine; Remission Induction; Transplantation, Autologous; Vincristine

2003
Limited field radiotherapy for early stage, infra-diaphragmatic Hodgkin's lymphoma.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 2004, Volume: 16, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Chlorambucil; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisolone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine

2004
Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    International journal of radiation oncology, biology, physics, 2004, Mar-15, Volume: 58, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Feasibility Studies; Germany; Hodgkin Disease; Humans; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2004
Low acute hematological toxicity during chemotherapy predicts reduced disease control in advanced Hodgkin's disease.
    Annals of hematology, 2004, Volume: 83, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Glyoxal; Hematologic Diseases; Hodgkin Disease; Humans; Ifosfamide; Male; Prednimustine; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Severity of Illness Index; Treatment Outcome; Vinblastine; Vincristine

2004
ChlVPP/ABVVP, a first line 'hybrid' combination chemotherapy for advanced Hodgkin's lymphoma: a retrospective analysis.
    British journal of haematology, 2004, Volume: 125, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Disease-Free Survival; Doxorubicin; Etoposide; Female; Gastrointestinal Diseases; Hematologic Diseases; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasms, Second Primary; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2004
Long-term outcome of oligodendrogliomas.
    Neurology, 2004, May-25, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dacarbazine; Epilepsies, Partial; Etoposide; Female; Follow-Up Studies; Humans; Life Tables; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoadjuvant Therapy; Nitrosourea Compounds; Oligodendroglioma; Organophosphorus Compounds; Procarbazine; Prognosis; Proportional Hazards Models; Radionuclide Imaging; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Temozolomide; Treatment Outcome; Vincristine

2004
Teaching cases from the Royal Marsden and St Mary's Hospitals, case 26: refractory microcytic anaemia.
    Leukemia & lymphoma, 2004, Volume: 45, Issue:7

    Topics: Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Blood Sedimentation; C-Reactive Protein; Chlorambucil; Cough; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Inflammation; Male; Middle Aged; Prednisolone; Procarbazine; Remission Induction; Splenomegaly; Tomography, Emission-Computed; Tomography, X-Ray Computed; Vinblastine; Vincristine

2004
Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Mar-01, Volume: 23, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Salvage Therapy; Survival Rate; Treatment Failure; Vinblastine; Vincristine

2005
[Treatment of primary mediastinal large B-cell lymphomas].
    Orvosi hetilap, 2004, Dec-12, Volume: 145, Issue:50

    Topics: Adult; Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisolone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine

2004
Modified ProMACE-MOPP hybrid regimen with moderate-dose methotrexate for patients with primary CNS lymphoma.
    Annals of hematology, 2005, Volume: 84, Issue:7

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leukopenia; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Pneumonia; Prednisone; Procarbazine; Retrospective Studies; Sepsis; Vincristine

2005
New treatment options have changed the survival of patients with follicular lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Nov-20, Volume: 23, Issue:33

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Leucovorin; Lymphoma, Follicular; Male; Mechlorethamine; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Procarbazine; Proportional Hazards Models; Prospective Studies; Survival Rate; United States; Vincristine

2005
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Oct-20, Volume: 23, Issue:30

    Topics: Adolescent; Adult; Age Factors; Aged; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contraceptives, Oral; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Menstrual Cycle; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2005
BEACOPP and COPP/ABVD as salvage treatment after primary extended field radiation therapy of early stage Hodgkins disease - results of the German Hodgkin Study Group.
    Leukemia & lymphoma, 2005, Volume: 46, Issue:11

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Databases, Factual; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Radiation Dosage; Radiotherapy; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine

2005
Evolving approaches to primary treatment of Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Neoplasm Staging; Prednisone; Procarbazine; Reed-Sternberg Cells; Stem Cell Transplantation; Vinblastine; Vincristine

2005
Therapies for relapsed Hodgkin lymphoma: transplant and non-transplant approaches including immunotherapy.
    Hematology. American Society of Hematology. Education Program, 2005

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Incidence; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Recurrence; Stem Cell Transplantation; Vinblastine; Vincristine

2005
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Mediastinal Neoplasms; Positron-Emission Tomography; Prednisone; Procarbazine; Thymus Hyperplasia; Tomography, X-Ray Computed; Vinblastine; Vincristine

2006
Will it be another 20 years before Hodgkin lymphoma patients benefit from BEACOPP therapy?
    Nature clinical practice. Oncology, 2006, Volume: 3, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prospective Studies; Randomized Controlled Trials as Topic; Survival Analysis; Time Factors; Vincristine

2006
Evaluation of acute and early cardiotoxicity in survivors of Hodgkin's disease treated with ABVD or BEACOPP regimens.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:2

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Echocardiography; Etoposide; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Prospective Studies; Survivors; Ventricular Function, Left; Vinblastine; Vincristine

2006
Sequential multidrug chemotherapy (CHOP-VA-MB) in patients with high-grade non-Hodgkin's lymphoma--a 20-year follow-up.
    Annals of hematology, 2006, Volume: 85, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Time Factors; Vincristine

2006
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2006, Sep-01, Volume: 66, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Incidence; Lung; Male; Mediastinum; Middle Aged; Prednisone; Procarbazine; Radiation Pneumonitis; Radiotherapy Dosage; Retrospective Studies; Risk Factors; Stem Cell Transplantation; Vinblastine; Vincristine

2006
High-grade glioma in children under 5 years of age: a chemotherapy only approach with the BBSFOP protocol.
    European journal of cancer (Oxford, England : 1990), 2006, Volume: 42, Issue:17

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Child, Preschool; Cisplatin; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Glioma; Humans; Infant; Male; Neoplasm, Residual; Procarbazine; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine

2006
[Limphomatous meningitis as recurrence site in Hodgkin's disease].
    Medicina, 2006, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Diagnosis, Differential; Doxorubicin; Etoposide; Fatal Outcome; Hodgkin Disease; Humans; Leukoencephalopathy, Progressive Multifocal; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Vinblastine; Vincristine

2006
Information sources used by New South Wales cancer clinicians: a qualitative study.
    Internal medicine journal, 2006, Volume: 36, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Information Services; Etoposide; Female; Health Personnel; Hodgkin Disease; Hospitals, Public; Humans; Internet; Interviews as Topic; Male; Medical Oncology; Middle Aged; Neoplasms; New South Wales; Online Systems; Prednisone; Procarbazine; Vincristine

2006
Astrocytic tumors in children: treatment results from a single institution.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2007, Volume: 23, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Humans; Infant; Lomustine; Male; Neurosurgical Procedures; Prednisone; Procarbazine; Radiotherapy; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

2007
[Our experiences in treating patients with Hodgkin disease in the last decade].
    Orvosi hetilap, 2007, Apr-15, Volume: 148, Issue:15

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Hungary; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2007
[Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
    Deutsche medizinische Wochenschrift (1946), 2007, Volume: 132, Issue:33

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymph Nodes; Male; Melphalan; Middle Aged; Neoplasm Recurrence, Local; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vinblastine; Vincristine

2007
Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma.
    Leukemia & lymphoma, 2008, Volume: 49, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Humans; Leukocyte Count; Lymphoma, Mantle-Cell; Middle Aged; Prednisone; Procarbazine; Recurrence; Retrospective Studies; Treatment Outcome

2008
High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Cancer, 2008, Apr-15, Volume: 112, Issue:8

    Topics: Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cisplatin; Cohort Studies; Disease Progression; Etoposide; Female; Follow-Up Studies; Humans; Lomustine; Male; Medulloblastoma; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Procarbazine; Retrospective Studies; Stem Cell Transplantation; Survival Rate; Thiotepa; Transplantation, Autologous

2008
Hodgkin's Lymphoma in an elite endurance athlete.
    Medicine and science in sports and exercise, 2008, Volume: 40, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Germany; Hemoglobins; Hodgkin Disease; Humans; Male; Physical Endurance; Prednisone; Procarbazine; Sports; Vincristine

2008
Results of treatment of 112 cases of primary CNS lymphoma.
    Japanese journal of clinical oncology, 2008, Volume: 38, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cognition; Cranial Irradiation; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Leucovorin; Lymphoma; Male; Mechlorethamine; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vincristine

2008
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
    Voprosy onkologii, 2008, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Prognosis; Radionuclide Imaging; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Vinblastine; Vincristine

2008
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Azoospermia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fertility; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Luteinizing Hormone; Male; Middle Aged; Prednisone; Procarbazine; Semen; Spermatozoa; Testosterone; Vinblastine; Vincristine

2008
In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.
    British journal of cancer, 2008, Jul-22, Volume: 99, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Carboplatin; Cell Line, Tumor; Cisplatin; Dacarbazine; Drug Screening Assays, Antitumor; Etoposide; Female; Glioblastoma; Glioma; Hepatocytes; Humans; Lomustine; Male; Membrane Glycoproteins; Middle Aged; Procarbazine; Recombinant Fusion Proteins; Temozolomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha; Vincristine

2008
[Efficacy of therapy of different variants of anaplastic large T-cell lymphomas].
    Terapevticheskii arkhiv, 2008, Volume: 80, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Cyclophosphamide; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission Induction; Treatment Outcome; Vincristine

2008
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
    Blood, 2009, Apr-02, Volume: 113, Issue:14

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Frequency; Glucuronosyltransferase; Hodgkin Disease; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Young Adult

2009
Combination of rituximab and chemotherapy showing anti-tumor effect in gamma heavy chain disease expressing CD20.
    American journal of hematology, 2008, Volume: 83, Issue:12

    Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide; Fatal Outcome; Heavy Chain Disease; Humans; Immunoglobulin gamma-Chains; Male; Prednisone; Procarbazine; Rituximab

2008
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Anticancer research, 2009, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult

2009
Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2009, Jul-20, Volume: 27, Issue:21

    Topics: Administration, Oral; Adolescent; Adult; Africa South of the Sahara; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; HIV Infections; HIV-1; Humans; Kenya; Lomustine; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Procarbazine; Treatment Outcome; Uganda; Virus Replication; Young Adult

2009
Nail dystrophy due to dose-intensive chemotherapy.
    International journal of hematology, 2009, Volume: 90, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Nail Diseases; Prednisone; Procarbazine; Vincristine

2009
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
    Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Male; Mesna; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine; Vinorelbine

2009
Is there a role for BEACOPP (bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, prednisone) in relapsed Hodgkin lymphoma?
    Leukemia & lymphoma, 2009, Volume: 50, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Recurrence; Survival Analysis; Treatment Outcome; Vincristine

2009
First reported case of disease: peliosis hepatis as cardinal symptom of Hodgkin's lymphoma.
    The oncologist, 2009, Volume: 14, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Etoposide; Female; Hodgkin Disease; Humans; Peliosis Hepatis; Prednisone; Procarbazine; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2009
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Dexamethasone; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Hodgkin Disease; Humans; Male; Mechlorethamine; Melphalan; Organoplatinum Compounds; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Prednisolone; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Thalidomide; Topotecan; Transplantation, Autologous; Vidarabine; Vinblastine; Vincristine

2010
The early- and intermediate-term toxicity to primitive hematopoietic progenitor cells of three chemotherapy regimens for advanced hodgkin lymphoma.
    Clinical lymphoma & myeloma, 2009, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine

2009
Hodgkin lymphoma presenting with hair graying.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hair Color; Hodgkin Disease; Humans; Prednisone; Procarbazine; Prognosis; Vincristine

2010
Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.
    Journal of the National Cancer Institute, 2010, Jun-16, Volume: 102, Issue:12

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bendamustine Hydrochloride; Bleomycin; Chlorambucil; Controlled Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Exercise; Hematinics; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Multicenter Studies as Topic; Myelodysplastic Syndromes; Nitrogen Mustard Compounds; Prednisone; Procarbazine; Quality of Life; Randomized Controlled Trials as Topic; Vinblastine; Vincristine

2010
Modified escalated BEACOPP as salvage chemotherapy in classic Hodgkin lymphoma.
    International journal of hematology, 2010, Volume: 92, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Salvage Therapy; Treatment Outcome; Vincristine

2010
Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: the GPOH-HD-2002 study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Aug-10, Volume: 28, Issue:23

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Treatment Outcome; Vincristine

2010
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2011, Volume: 22, Issue:3

    Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine

2011
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult

2010
Role of [18F]-fluoro-2-deoxy-D-glucose positron emission tomography in early and late therapy assessment of patients with advanced Hodgkin lymphoma treated with bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine and prednisone.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Radiopharmaceuticals; Time Factors; Treatment Outcome; Vincristine; Young Adult

2012
Hodgkin's lymphoma--the great teacher.
    The New England journal of medicine, 2011, Jul-21, Volume: 365, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Salvage Therapy; Vinblastine; Vincristine

2011
Chemotherapy: Advanced Hodgkin lymphoma--balancing toxicity and cure.
    Nature reviews. Clinical oncology, 2011, Sep-06, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Consolidation Chemotherapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Induction Chemotherapy; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2011
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Cyclophosphamide; Disease Progression; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Osteonecrosis; Practice Guidelines as Topic; Prednisone; Procarbazine; Retrospective Studies; Risk; Survival Analysis; Vincristine; Young Adult

2012
A 10-year experience with treatment of high and standard risk Hodgkin disease: six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved.
    American journal of hematology, 2012, Volume: 87, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Fertility Preservation; Hodgkin Disease; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Sex Factors; Survival Analysis; Tomography, X-Ray Computed; Vincristine; Young Adult

2012
Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.
    Journal of experimental & clinical cancer research : CR, 2011, Oct-05, Volume: 30

    Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents; Asparaginase; Bayes Theorem; Data Mining; Docetaxel; Drug Hypersensitivity; Etoposide; Humans; Paclitaxel; Pharmacovigilance; Procarbazine; Prognosis; Taxoids; Teniposide; United States; United States Food and Drug Administration

2011
Chemotherapy: Hodgkin lymphoma--absence of evidence not evidence of absence!
    Nature reviews. Clinical oncology, 2011, Oct-04, Volume: 8, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Disease Progression; Disease-Free Survival; Doxorubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Remission Induction; Research Design; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2011
More is not necessarily better when treating Hodgkin's lymphoma.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Prednisone; Procarbazine; Vincristine

2011
Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
    British journal of haematology, 2012, Volume: 156, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diffusion Magnetic Resonance Imaging; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Radiopharmaceuticals; Tomography, X-Ray Computed; Treatment Outcome; Vincristine

2012
[Acquired ichthyosis and haematological malignancies: five cases].
    Annales de dermatologie et de venereologie, 2012, Volume: 139, Issue:1

    Topics: Adult; Aged; Allopurinol; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematologic Neoplasms; Hodgkin Disease; Humans; Ichthyosis; Imatinib Mesylate; Leukemia, Myeloid, Accelerated Phase; Lung Neoplasms; Lymphoma, B-Cell; Male; Middle Aged; Paraneoplastic Syndromes; Parotid Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prednisone; Procarbazine; Pyrimidines; Retrospective Studies; Rituximab; Schizophrenia; Stomach Neoplasms; Vincristine

2012
Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:7

    Topics: Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Logistic Models; Menopause; Menstrual Cycle; Middle Aged; Multivariate Analysis; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Vinblastine; Vincristine; Young Adult

2012
Homonymous hemianopsia in a patient with Hodgkin's lymphoma in remission after BEACOPP chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2012, Apr-20, Volume: 30, Issue:12

    Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hemianopsia; Hodgkin Disease; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Vincristine

2012
Escalated BEACOPP in advanced Hodgkin's lymphoma.
    Lancet (London, England), 2012, May-12, Volume: 379, Issue:9828

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prednisone; Procarbazine; Vincristine

2012
Metronomic therapy for refractory/relapsed lymphoma: the PEP-C low-dose oral combination chemotherapy regimen.
    Hematology (Amsterdam, Netherlands), 2012, Volume: 17 Suppl 1

    Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Endothelial Cells; Etoposide; Gene Expression Regulation, Neoplastic; Humans; Lymphoma; Prednisone; Procarbazine; Receptors, Vascular Endothelial Growth Factor; Secondary Prevention; Vascular Endothelial Growth Factor A

2012
Optic glioma in children: a retrospective analysis of 101 cases.
    American journal of clinical oncology, 2013, Volume: 36, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Etoposide; Female; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Neoplasm Staging; Optic Nerve Glioma; Prednisolone; Procarbazine; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Rate; Vincristine

2013
A malignant lymphoma with histological features and immunophenotypic profile intermediate between EBV-positive diffuse large B-cell lymphoma and EBV-positive classical Hodgkin lymphoma in a 67-year-old female: a "gray zone" lymphoma associated with Epstei
    Pathology, research and practice, 2012, Jun-15, Volume: 208, Issue:6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epstein-Barr Virus Infections; Etoposide; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunophenotyping; Ki-1 Antigen; Lewis X Antigen; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine; Reed-Sternberg Cells; Remission Induction; Vincristine

2012
[The optimal radiation volume after first-line chemotherapy in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Role of response to first-line chemotherapy and of the primary lesion in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Primary refractory and relapsed Hodgkin lymphoma with unfavorable prognosis].
    Voprosy onkologii, 2012, Volume: 58, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine

2012
Clinical characteristics of the patients with Hodgkin's lymphoma involving extranodal sites.
    Chinese journal of cancer, 2012, Volume: 31, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Remission Induction; Retrospective Studies; Survival Rate; Vinblastine; Vincristine; Young Adult

2012
Autotransplant for Hodgkin lymphoma after failure of upfront BEACOPP escalated (bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine and prednisone).
    Leukemia & lymphoma, 2013, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Retrospective Studies; Transplantation, Autologous; Transplantation, Homologous; Treatment Failure; Vincristine; Young Adult

2013
[Relapse in Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:2

    Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Prognosis; Recurrence; Retrospective Studies; Risk Assessment; Risk Factors; Serum Albumin; Treatment Outcome; Vinblastine; Vincristine

2012
Bendamustine salvage for the treatment of relapsed Hodgkin's lymphoma after allogeneic bone marrow transplantation.
    Annals of hematology, 2013, Volume: 92, Issue:1

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Bleomycin; Bone Marrow Transplantation; Chemical and Drug Induced Liver Injury; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Deoxycytidine; Doxorubicin; Etoposide; Fatal Outcome; Female; Gemcitabine; Graft vs Host Disease; Hodgkin Disease; Humans; Ifosfamide; Male; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Recurrence; Reoperation; Rituximab; Salvage Therapy; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine; Vinorelbine; Young Adult

2013
Nodular sclerosing Hodgkin's disease mimicking Riedel's invasive fibrous thyroiditis.
    Annales d'endocrinologie, 2012, Volume: 73, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Fine-Needle; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Fibrosis; Hodgkin Disease; Humans; Immunoglobulin G; Positron-Emission Tomography; Prednisone; Procarbazine; Thyroid Gland; Thyroiditis; Tomography, X-Ray Computed; Vincristine

2012
Cryptococcal osteomyelitis and meningitis in a patient with non-hodgkin's lymphoma treated with PEP-C.
    BMJ case reports, 2012, Sep-07, Volume: 2012

    Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Cryptococcus neoformans; Cyclophosphamide; Etoposide; Humans; Lymphoma, Non-Hodgkin; Male; Meningitis, Cryptococcal; Osteomyelitis; Prednisone; Procarbazine

2012
[Escalated BEACOPP as an alternative in high risk Hodgkin lymphoma].
    Przeglad lekarski, 2012, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron-Emission Tomography; Prednisone; Procarbazine; Vincristine; Young Adult

2012
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2012, Volume: 16, Issue:7

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopathy, Dilated; Chemoradiotherapy; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Ifosfamide; Male; Mechlorethamine; Photons; Prednisone; Procarbazine; Radiotherapy Dosage; Remission Induction; Retrospective Studies; Risk Factors; Treatment Outcome; Tunisia; Vincristine

2012
Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Jan-10, Volume: 31, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follicle Stimulating Hormone; Germany; Gonadotropin-Releasing Hormone; Hodgkin Disease; Humans; Inhibins; Male; Menstrual Cycle; Middle Aged; Oligospermia; Ovary; Prednisone; Pregnancy; Procarbazine; Randomized Controlled Trials as Topic; Survivors; Testis; Testosterone; Vinblastine; Vincristine; Young Adult

2013
[Successful treatment for Hodgkin's lymphoma in a female patient with Ph+ chronic myeloid leukemia].
    Terapevticheskii arkhiv, 2012, Volume: 84, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Prednisone; Procarbazine; Pyrimidines; Remission Induction; Treatment Outcome; Vincristine

2012
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:9

    Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma, Large B-Cell, Diffuse; Prednisone; Procarbazine; Remission Induction; Rituximab; Treatment Outcome; Vincristine

2013
The impact of systemic chemotherapy on testicular FDG activity in young men with Hodgkin's lymphoma.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biological Transport; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prednisone; Procarbazine; Retrospective Studies; Sperm Count; Testis; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult

2013
Treatment of children and adolescents with Hodgkin lymphoma without radiotherapy for patients in complete remission after chemotherapy: final results of the multinational trial GPOH-HD95.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Apr-20, Volume: 31, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; International Agencies; Male; Neoplasm Grading; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Rate; Vidarabine; Vincristine

2013
[The optimal total focal radiotherapy dosage after first-line chemotherapy in patients with Hodgkin lymphoma].
    Voprosy onkologii, 2012, Volume: 58, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm, Residual; Prednisone; Procarbazine; Radiotherapy Dosage; Radiotherapy, Adjuvant; Treatment Outcome; Vinblastine; Vincristine

2012
[Treatment of advanced Hodgkin lymphoma].
    Deutsche medizinische Wochenschrift (1946), 2013, Volume: 138, Issue:23

    Topics: Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cause of Death; Climacteric; Cyclophosphamide; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Molecular Targeted Therapy; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Voprosy onkologii, 2013, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Risk Assessment; Risk Factors; Treatment Outcome; Vinblastine; Vincristine

2013
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
    Journal of the National Cancer Institute, 2013, Aug-07, Volume: 105, Issue:15

    Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine

2013
Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma.
    Anticancer research, 2013, Volume: 33, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Immunoconjugates; Middle Aged; Multimodal Imaging; Prednisone; Procarbazine; Vinblastine; Vincristine

2013
Early treatment intensification with escalated BEACOPP in patients with Hodgkins lymphoma not responding to ABVD therapy.
    Acta oncologica (Stockholm, Sweden), 2014, Volume: 53, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Vincristine; Young Adult

2014
Treatment of Hodgkin lymphoma: a 50-year perspective.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jan-20, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Europe; History, 20th Century; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group.
    Blood, 2014, Mar-13, Volume: 123, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Germany; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Incidence; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Young Adult

2014
[Stevens-Johnson syndrome and Hodgkin's disease: A fortuitous association or paraneoplastic syndrome?].
    Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Causality; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Male; Neoplasm Staging; Paraneoplastic Syndromes; Prednisone; Procarbazine; Recurrence; Remission Induction; Stevens-Johnson Syndrome; Vinblastine; Vincristine; Young Adult

2014
Vanishing bile duct-like syndrome in a patient with Hodgkin lymphoma - pathological development and restitution.
    Acta oncologica (Stockholm, Sweden), 2014, Volume: 53, Issue:9

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bile Ducts, Intrahepatic; Bleomycin; Carrier Proteins; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Jaundice; Male; Neoplasm Staging; Prednisone; Procarbazine; Rituximab; Syndrome; Vincristine

2014
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
    British journal of haematology, 2014, Volume: 165, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine

2014
Etravirine: a good option for concomitant use with chemotherapy for Hodgkin's lymphoma.
    International journal of STD & AIDS, 2015, Volume: 26, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Fever; HIV Infections; HIV-1; Hodgkin Disease; Humans; Male; Middle Aged; Nitriles; Prednisone; Procarbazine; Pyridazines; Pyrimidines; Reverse Transcriptase Inhibitors; Treatment Outcome; Vincristine; Viral Load

2015
Which Hodgkin's patients in the Unites States should be treated with BEACOPP?
    Current hematologic malignancy reports, 2014, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Prednisone; Procarbazine; United States; Vinblastine; Vincristine

2014
Ten years' experience with four cycles of bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, prednisone, procarbazine (BEACOPP)-escalated followed by four cycles of baseline-dose BEACOPP in patients with advanced stage Hodgkin lymphoma: a s
    Leukemia & lymphoma, 2015, Volume: 56, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Time Factors; Vincristine; Young Adult

2015
PET2 -driven de-escalation therapy in 64 high-risk Hodgkin Lymphoma patients treated with escalated BEACOPP.
    British journal of haematology, 2015, Volume: 170, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Procarbazine; Treatment Outcome; Vincristine

2015
Successful rapid desensitization to the antibody-drug conjugate brentuximab vedotin in a patient with refractory Hodgkin lymphoma.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2016, Volume: 22, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Immunoconjugates; Ki-1 Antigen; Male; Prednisone; Procarbazine; Vincristine

2016
[Necrotizing gastritis in a patient in severe neutropenia].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2014, Volume: 37, Issue:222

    Topics: Abdominal Pain; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Enteral Nutrition; Esophagostomy; Etoposide; Female; Gastrectomy; Gastritis; Gastrointestinal Hemorrhage; Heart Arrest; Hodgkin Disease; Humans; Jejunostomy; Neutropenia; Prednisone; Procarbazine; Stents; Vincristine

2014
Does interim PET increase the value of ABVD in advanced-stage Hodgkin lymphoma?
    Annals of oncology : official journal of the European Society for Medical Oncology, 2015, Volume: 26, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Positron-Emission Tomography; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vinblastine; Vincristine

2015
[Hodgkin's lymphoma and radiotherapy].
    Voprosy onkologii, 2015, Volume: 61, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Chemotherapy, Adjuvant; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy Dosage; Recurrence; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine

2015
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
    Voprosy onkologii, 2015, Volume: 61, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemoradiotherapy; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine

2015
Mortality in Children with Optic Pathway Glioma Treated with Up-Front BB-SFOP Chemotherapy.
    PloS one, 2015, Volume: 10, Issue:6

    Topics: Antineoplastic Agents; Astrocytoma; Carboplatin; Child; Child, Preschool; Cisplatin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Etoposide; Female; France; Humans; Infant; Male; Optic Nerve Glioma; Procarbazine; Survival Rate; Vincristine

2015
[Rituximab combined with second line regimens for treatment of seven relapsed and refractory Hodgkin lymphoma patients].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2015, Volume: 36, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cisplatin; Cyclophosphamide; Deoxycytidine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Remission Induction; Rituximab; Salvage Therapy; Vinblastine; Vincristine; Vinorelbine; Young Adult

2015
[Efficacy of R±BEACOP regimen in patients with 
poor-prognosis lymphoma].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2015, Volume: 40, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Rituximab; Vincristine

2015
High-Risk, Advanced-Stage Hodgkin Lymphoma: The Impact of Combined Escalated BEACOPP and ABVD Treatment in Patients Who Rapidly Achieve Metabolic Complete Remission on Interim FDG-PET/CT Scan.
    Acta haematologica, 2016, Volume: 135, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hodgkin Disease; Humans; Male; Neoplasm Staging; Neoplasms, Second Primary; Positron-Emission Tomography; Prednisone; Procarbazine; Remission Induction; Tomography, X-Ray Computed; Treatment Outcome; Vinblastine; Vincristine

2016
Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
    Journal of assisted reproduction and genetics, 2016, Volume: 33, Issue:3

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Female; Fertility; Fertility Preservation; Follow-Up Studies; Hodgkin Disease; Humans; Infertility, Female; Infertility, Male; Male; Pregnancy; Procarbazine; Surveys and Questionnaires; Vinblastine; Vincristine; Young Adult

2016
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.
    Human reproduction (Oxford, England), 2016, Volume: 31, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Infertility, Male; Longitudinal Studies; Male; Prednisone; Procarbazine; Retrospective Studies; Semen Analysis; Spermatogenesis; Spermatozoa; Vinblastine; Vincristine

2016
Treating Adults with Hodgkin Lymphoma in the Developing World: a Hospital-Based Cohort Study from Armenia.
    Asian Pacific journal of cancer prevention : APJCP, 2016, Volume: 17, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Armenia; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Developed Countries; Doxorubicin; Etoposide; Female; Hodgkin Disease; Hospitals; Humans; Lymphoma; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Retrospective Studies; Vinblastine; Vincristine; Young Adult

2016
Successful treatment of two cases of classical Hodgkin lymphoma-associated hemophagocytic lymphohistiocyosis with R-CEPP.
    Leukemia & lymphoma, 2017, Volume: 58, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biopsy; Bone Marrow; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Positron Emission Tomography Computed Tomography; Prednisolone; Procarbazine; Treatment Outcome

2017
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP.
    European radiology, 2017, Volume: 27, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Glucocorticoids; Hodgkin Disease; Humans; Image Interpretation, Computer-Assisted; Incidence; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Osteonecrosis; Prednisone; Procarbazine; Retrospective Studies; Vincristine; Whole Body Imaging; Young Adult

2017
HD2000 Update in Hodgkin Lymphoma-ABVD or BEACOPP?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 10-10, Volume: 34, Issue:29

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Procarbazine; Vinblastine; Vincristine

2016
Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2017, 01-20, Volume: 35, Issue:3

    Topics: Child; Cyclophosphamide; Etoposide; Hodgkin Disease; Humans; Positron-Emission Tomography; Procarbazine; Vincristine

2017
A rare case of Hodgkin's lymphoma presenting with papulonecrotic tuberculid.
    BMJ case reports, 2017, Jul-13, Volume: 2017

    Topics: Aged; Antineoplastic Agents; Biopsy; Cyclophosphamide; Diagnosis, Differential; Etoposide; Glucocorticoids; Hodgkin Disease; Humans; Male; Prednisolone; Procarbazine; Skin; Tuberculosis, Cutaneous

2017
PET-positive bone lesion due to Langerhans cell histiocytosis after BEACOPP therapy for Hodgkin lymphoma: how anamnesis, histopathological accuracy, and molecular analysis could resolve a clinical dilemma.
    Annals of hematology, 2018, Volume: 97, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Bone Marrow; Causality; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cells; Histiocytosis, Langerhans-Cell; Hodgkin Disease; Humans; Langerhans Cells; Laser Capture Microdissection; Middle Aged; Neoplasm Proteins; Point Mutation; Positron-Emission Tomography; Prednisone; Procarbazine; Proto-Oncogene Proteins B-raf; Reed-Sternberg Cells; Temporal Bone; Vincristine

2018
High incidence of aseptic hip necrosis in Hodgkin lymphoma patients treated with escalated BEACOPP receiving methylprednisolone.
    Internal medicine journal, 2018, Volume: 48, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Sectional Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Glucocorticoids; Hodgkin Disease; Humans; Incidence; Male; Methylprednisolone; Osteonecrosis; Pelvic Bones; Prednisone; Procarbazine; Treatment Outcome; Vincristine; Young Adult

2018
Model-based optimization of G-CSF treatment during cytotoxic chemotherapy.
    Journal of cancer research and clinical oncology, 2018, Volume: 144, Issue:2

    Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoiesis; Humans; Leukopenia; Models, Biological; Neoplasms; Polyethylene Glycols; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Reproducibility of Results; Vincristine

2018
Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma.
    Clinical journal of gastroenterology, 2018, Volume: 11, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Cyclophosphamide; Etoposide; Female; Hepatomegaly; Humans; Immunoblastic Lymphadenopathy; Liver; Lymphoma, T-Cell; Mitochondria; Prednisone; Procarbazine; Splenomegaly

2018
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy.
    Annals of hematology, 2018, Volume: 97, Issue:6

    Topics: Adolescent; Adult; Aged; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count; Cohort Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Monocytes; Neoplasm Staging; Neutrophils; Positron-Emission Tomography; Prednisone; Procarbazine; Prognosis; Retrospective Studies; Survival Analysis; Vincristine; Young Adult

2018
[Tunisian National Protocol for Adult Hodgkin's Lymphoma Treatment: Results of a therapeutic regimen adapted to the 2-cycle CT response, about 444 patients].
    Bulletin du cancer, 2018, Volume: 105, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Recurrence; Survival Analysis; Treatment Outcome; Tunisia; Vincristine

2018
Osteonecrosis in Hodgkin lymphoma treated by BEACOPP.
    Internal medicine journal, 2018, Volume: 48, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Osteonecrosis; Prednisone; Procarbazine; Treatment Outcome; Vincristine

2018
Bleomycin-Induced Flagellate Dermatitis
    Turkish journal of haematology : official journal of Turkish Society of Haematology, 2019, May-03, Volume: 36, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Eruptions; Etoposide; Female; Hodgkin Disease; Humans; Prednisone; Procarbazine; Vincristine

2019
Early chemotherapy de-escalation strategy in patients with advanced-stage Hodgkin lymphoma with negative positron emission tomography scan after 2 escalated BEACOPP cycles.
    Polish archives of internal medicine, 2019, 04-30, Volume: 129, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine

2019
Sarcoidosis following escalated BEACOPP chemotherapy for stage IV Hodgkin lymphoma.
    Internal medicine journal, 2019, Volume: 49, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Sarcoidosis; Vincristine

2019
Protontherapy versus best photon for mediastinal Hodgkin lymphoma: Dosimetry comparison and treatment using ILROG guidelines.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2019, Volume: 23, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Heart; Hodgkin Disease; Humans; Lung; Mediastinal Neoplasms; Organ Sparing Treatments; Organs at Risk; Photons; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prednisone; Procarbazine; Proton Therapy; Radiation Injuries; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Intensity-Modulated; Vincristine; Young Adult

2019
Retrospective analysis of clinical features and treatment outcomes of children with Hodgkin's Lymphoma treated with different chemotherapy protocols at a tertiary care center in Pakistan.
    JPMA. The Journal of the Pakistan Medical Association, 2019, Volume: 69, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Staging; Pakistan; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies; Survival Rate; Tertiary Care Centers; Treatment Outcome; Vinblastine; Vincristine

2019
Heart on the wrong side.
    Australian journal of general practice, 2019, Volume: 48, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Dyspnea; Etoposide; Hematuria; Hepatomegaly; Hodgkin Disease; Humans; Lower Urinary Tract Symptoms; Lymphadenopathy; Male; Marfan Syndrome; Mediastinum; Neoplasm Staging; Pectus Carinatum; Pleural Effusion; Prednisone; Procarbazine; Splenomegaly; Tomography, X-Ray Computed; Vinblastine; Vincristine; Young Adult

2019
What to Do With Deauville 3 Interim Positron Emission Tomography/Computed Tomography Response in a Young Woman With Classic Unfavorable Hodgkin's Lymphoma: To Irradiate or Not to Irradiate?
    International journal of radiation oncology, biology, physics, 2020, 01-01, Volume: 106, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Mediastinal Neoplasms; Positron Emission Tomography Computed Tomography; Prednisone; Procarbazine; Vinblastine; Vincristine

2020
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Mechlorethamine; Mediastinal Neoplasms; Middle Aged; Organs at Risk; Prednisone; Procarbazine; Radiotherapy Dosage; Recurrence; Retrospective Studies; Treatment Outcome; Tunisia; Vinblastine; Vincristine; Young Adult

2020
Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2.
    British journal of haematology, 2020, Volume: 190, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Betacoronavirus; Bleomycin; Coronavirus Infections; COVID-19; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Hydroxychloroquine; Idarubicin; Mediastinal Neoplasms; Pandemics; Pneumonia, Viral; Positron-Emission Tomography; Prednisone; Procarbazine; SARS-CoV-2; Treatment Outcome; Vinblastine; Vincristine

2020
A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
    Medicine, 2020, May-22, Volume: 99, Issue:21

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dermatologic Agents; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Prednisone; Procarbazine; Psoriasis; Ustekinumab; Vincristine; Young Adult

2020
Relapse After Early-Stage, Favorable Hodgkin Lymphoma: Disease Characteristics and Outcomes With Conventional or High-Dose Chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2021, 01-10, Volume: 39, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Progression-Free Survival; Proportional Hazards Models; Randomized Controlled Trials as Topic; Recurrence; Stem Cell Transplantation; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2021
Evaluation of ovarian reserve before and after chemotherapy.
    Journal of gynecology obstetrics and human reproduction, 2021, Volume: 50, Issue:5

    Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult

2021
Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial.
    Annals of hematology, 2021, Volume: 100, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; England; Etoposide; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multicenter Studies as Topic; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Procarbazine; Progression-Free Survival; Retrospective Studies; Treatment Outcome; Vinblastine; Vincristine; Young Adult

2021
PET-2-guided escalated BEACOPP for advanced nodular lymphocyte-predominant Hodgkin lymphoma: a subgroup analysis of the randomized German Hodgkin Study Group HD18 study.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2021, Volume: 32, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lymphocytes; Positron-Emission Tomography; Prednisone; Procarbazine; Vincristine

2021
Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP.
    Leukemia, 2021, Volume: 35, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemokine CCL17; Cyclophosphamide; Doxorubicin; Etoposide; Female; Gene Expression Profiling; Hodgkin Disease; Humans; Ki-1 Antigen; Male; Middle Aged; Neoplasm Staging; Predictive Value of Tests; Prednisone; Procarbazine; Receptor, Platelet-Derived Growth Factor alpha; Survival Rate; Transcriptome; Treatment Outcome; Vincristine; Young Adult

2021
Small lymphocytic lymphoma secondary to young patient with a history of classical Hodgkin Lymphoma.
    International journal of laboratory hematology, 2022, Volume: 44, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Neoplasms, Second Primary; Prednisone; Procarbazine; Vinblastine; Vincristine

2022
Study of a metronomic-chemotherapy regimen comprising prednisone, etoposide and procarbazine combined with thalidomide±Rituxan for relapsed refractory B-cell lymphoma.
    Asian journal of surgery, 2023, Volume: 46, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Lymphoma, B-Cell; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Rituximab; Thalidomide; Treatment Outcome

2023
'ACOPP' chemotherapy for older and less fit patients with Hodgkin lymphoma-A multicentre, retrospective study.
    British journal of haematology, 2023, Volume: 202, Issue:4

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Prednisone; Procarbazine; Retrospective Studies; Vincristine

2023